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ABSTRACT
Modeling the Growth and Dissolution of Clots
in Flowing Blood. (August 2005)
Anand Mohan, B.Tech., Indian Insitute of Technology, Madras;
M.S., Texas A&M University
Chair of Advisory Committee: Dr. K. R. Rajagopal
Multiple interacting mechanisms control the formation and dissolution of clots to
maintain blood in a state of delicate balance. In addition to a myriad of biochemical
reactions, rheological factors also play a crucial role in modulating the response of
blood to external stimuli. The broad stimuli for clot formation were laid out, more
than a century ago, in, what is now referred to as, Virchow’s triad. To date, a
comprehensive model for clot formation and dissolution, that takes into account the
biochemical, medical and rheological factors, has not been put into place, the existing
models emphasizing either one or the other of the factors. In this dissertation, a model
is developed for clot formation and dissolution that incorporates many of the relevant
crucial factors that have a bearing on the problem. The model, though just a first step
towards understanding a complex phenomenon goes further than previous models in
integrating the biochemical, medical and rheological factors that come into play. The
model is tested in some simple flow situations as part of an attempt to elucidate
Virchow’s triad. Extensions to the model, along with detailed numerical studies, will
hopefully aid in a clearer understanding of the phenomenon, and in making relevant
clinical correlations.
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1CHAPTER I
THE PHENOMENON OF HEMOSTASIS, ITS CLINICAL RELEVANCE, AND
THE ROLE OF MATHEMATICAL MODELING
The human body is fascinating for its complexity and the surprising ease with which it
maintains itself in a dynamic equilibrium (a process known as homeostasis) conducive
to the preservation of life. One among many interacting systems, the cardiovascu-
lar system, consisting in the heart and the vascular network of arteries, arterioles,
capillaries, venules and veins, is responsible for the circulation of blood, supplying
nutrition and oxygen to, and removing the byproducts of metabolism (nitrogenous
wastes, carbon dioxide) from, the trillions of cells in the body.
Blood, sometimes refered to as ‘the river of life’, consists in ‘cell’ matter (the
formed elements : red blood cells (RBCs), white blood cells (WBCs), platelets) in an
aqueous plasma solution. Plasma consists primarily of water in which various proteins
(fibrinogen, prothrombin, etc.) are dissolved along with ions (calcium (Ca2+), chloride
(Cl−), etc.). The vascular network branches into smaller vessels as oxygenated blood
flows away from the heart, and the thickness of the vessel walls decreases as well;
subsequently, there is a consolidation in vessel size as deoxygenated blood flows back
toward the heart. The walls of the large vessels (arteries and veins, between 0.1
mm and 30 mm in diameter) consist in three layers (the intima, the media and the
adventitia) whose thickness and composition vary along the entire vascular network
[46]. The intima consists of the endothelium that is in contact with blood, and
the subendothelial layer beneath that consists in several proteins (von Willebrand
Factor, collagen, etc.). The intima is separated from the media by a layer of elastin (a
The journal model is Interfaces and Free Boundaries.
2structural protein), the internal elastic lamina. The media consists mainly of smooth
muscle cells and the matrix of proteins these cells secrete and maintains the structural
integrity of the vessel, while the adventitia forms the outer layer between the vessel
and the surrounding tissue. The walls of the smaller vessels (arterioles, capillaries
and venules, less than 0.1 mm in diameter) consist primarily of the endothelial cell
layer, and a layer of pericytes beneath that are embedded in a matrix that contains
smooth muscle cells and the proteins secreted by both these cell types [50].
A. Hemostasis and Virchow’s triad
Numerous mechanisms have evolved to maintain blood in a state of delicate balance.
Factors and processes exist both to promote and inhibit clot formation, as well as, clot
maintenance. A fluid tissue under normal conditions, blood coagulates due to an im-
balance in favor of pro-thrombotic factors. In turn, clot maintenance is determined by
various stimuli like vessel wall injury, endothelial dysfunction, abnormally high shear
stresses, flow recirculation and stasis, etc. Under normal circumstances, the process
of clot formation, or hemostasis, is designed to seal defects in the cardiovascular sys-
tem and stem hemorrhage as part of a physiological response that precedes healing.
The eminent pathologist Rudolf Virchow, well over a century ago [113], laid out the
broad stimuli for thrombus formation : 1. local flow stasis/stagnation, 2. blood ves-
sel injury/endothelial dysfunction, 3. “Hypercoagulability” or an augmented native
tendency for blood to clot. This basic picture, or what is refered to as Virchow’s
triad, has been fleshed out with the greater details that have emerged in the years
since. The current understanding is that the endothelium plays a key role in main-
taining blood fluidity by balancing a natural tendency to clot in isolation with a set of
counteracting mechanisms (secretion of thrombomodulin, release of nitric oxide and
3PGI2 etc.). When the endothelium is disrupted, blood comes into contact with pro-
teins embedded in the subendothelial layers, and this initiates the formation of a clot.
Platelet activation and subsequent adhesion to the subendothelial surface is accom-
panied by platelet aggregation. Simultaneously, the extrinsic pathway of coagulation
(and the intrinsic pathway, although f-XII is not relevant in the in-vivo setting [37]),
particularly active in the setting of tissue damage, leads to the formation of throm-
bin, and hence the cleavage of fibrinogen to form fibrin monomers that polymerize
to form fibrin strands. Fibrinolysis, the process leading to the degradation of fibrin
molecules is signalled almost simulatneously with clot formation, and leads to the
dissolution of the clot. The entire process is host to multiple interacting mechanisms
that are carefully controlled so as to heal vascular injury and stem blood loss, with
only transient or no resultant tissue ischemia. In addition, rheological factors also
play a crucial role [43],[62],[110] in modulating the response at each level.
Typically, clot formation occurs only if the hemostatic stimuli reach a certain
threshold; this threshold is conditioned by both hemodynamic and biochemical fac-
tors including flow conditions, availability of membrane binding sites for catalysis,
concentration of di/multivalent ions like calcium (Ca2+), and, finally, concentrations
of the reagents involved in clot formation: platelets and coagulation factors. It is apt
to think of the mechanisms of hemostasis as being in a state of “system idling” due
to subthreshold stimuli, which is primed to respond explosively once this threshold
is crossed. During hemostasis, the system responds in a manner that will eventually
return it to its idling state while at the same time redressing the initial stimulus.
Pathological conditions may result as a consequence of either hypo- or hyper func-
tion of any or all of the components of the mechanisms of hemostasis. On the one
hand, hypofunction of these components results in impairments in clot function or
maintenance, i.e., bleeding disorders. On the other hand, hyperfunction of these
4functions results in inappropriate clot formation or maintenance, i.e., thrombotic or
thromboembolic disorders.
B. Clinical relevance
Disorders in thrombus formation or destruction govern several diseases, either wholly
or substantially, and the morbidity and mortality of such diseases is of significant
importance. Most of the common pathologies of the cardiovascular system result in
deleterious consequences, in large part, due to abnormalities of coagulation. Collec-
tively, these diseases are the leading cause of death in the developed world. It is useful
to classify patients into those with disorders of pathologic thrombus formation and
maintenance and conversely, those with disorders characterized by impaired thrombus
formation/maintenance (see [2] for a detailed review).
The first set of patients are organized anatomically based on the sites of patho-
logic thrombus or thromboembolus. This is done because the clinical manifestation
of these diseases and often the requisite therapies are governed by the site of throm-
bus/thromboembolus. Treatment of atrial thrombosis, for instance, centers on rate
control whereas artificial device technology in the form of Ventricular Assist Devices
(VADs) represents a modality in the treatment of ventricular thrombosis. Valvular
thrombosis is mostly a problem with artificial mechanical valves, but occurs, in rare
instances, on native valves, and is treated by anti-coagulation regimens. Arterial
thrombosis (acute coronary syndromes (ACS), and extremity arterial insufficiency
being two common and important examples; Figure 1 shows a picture of corononary
thrombosis where a thrombus occludes the coronary artery) is again treated very dif-
ferently, with the focus being on revascularization and concomitant anticoagulation.
The pathogenesis of Deep Venous Thrombi (DVT), with or without resultant pul-
5monary thrombo-embolism (PE), is understood within the framework of Virchow’s
triad. A myriad of hypercoagulable states (either Inherited or Acquired; see [9])
increase the risk of DVT formation, and while hereditary factors contribute to the
risk of inherited hypercoagulable states, hemodynamics plays a role in the acquired
states (especially post-surgical patients and postpartum patients, who are often in a
minimally ambulatory state). Endothelial dysfunction is also a risk factor for DVT
formation. Treatmentof DVT/PE typically focuses on anticoagulation regimes, and,
in some cases, placement of vena caval filters.
The second set of patients, in contrast, are organized based on the defective
hemostatic system component(s). This is because these diseases, while differing with
regards to etiology and pathogenesis, all manifest as bleeding disorders. These dis-
orders all have in common either inadequate levels of components in the hemostatic
system or dysfunction of these components. Treatment generally involves simple
replacement of deficient/defective components, or in some cases, pharmacologic en-
hancement of hemostatic system function. Broadly, treatment approaches involve: 1.
blood product administration and, 2. pharmacologic agents that augment platelet
function, coagulation factor function, or inhibit fibrinolysis.
The diagnosis of clinically relevant risk factors in patients presenting with either
pathologic thrombosis or bleeding disorders is of utmost importance in guiding the
management and treatment of the pathology. Laboratory evaluations involving global
tests of the hemostatic system (like the Prothrombin time (PT) and activated Partial
Thromboplastin Time (PTT) tests), and, if abnormal results ensue, a second tier of
tests either to determine specific biologic risk factors (in the cases where an inherited
hypercoagulable state is suspected; such tests involve immunologic and functional as-
says [9]) or to determine factor deficiencies, fibrinogen levels, von Willebrand disease,
etc. (in the cases where bleeding disorders are manifest; such tests involve repeat-
6Fig. 1. Coronary thrombosis: A thrombus occludes the lumen of the coronary artery;
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ing the PT and PTT after mixing the patient’s plasma with normal plasma and a
slew of chemical, immunochemical procedures [88]) form an important part of such
diagnosis. Mathematical modeling (theoretical modeling along with computational
methods) has emerged as a useful tool that can be used to complement such labo-
ratory evaluations and thus aid in confirming or even interpreting the results from a
laboratory evaluation. In addition, mathematical modeling helps in supplementing
experimental data and hence in forming a clearer picture of the hemostatic system.
C. The role of mathematical modeling
Constitutive modeling of blood has assumed increased importance with the realiza-
tion that the flow characteristics of blood influence the etiology and pathogenesis of
several cardiovascular diseases (for instance, in the stenosis of the coronary arteries
7due to thrombosis over atherosclerotic plaques, and in the possible embolism of such
thrombi). The development and testing of artificial devices used in the treatment
of ventricular thrombosis requires accurate, yet simple, models for describing blood
flow that can be used for computational simulations in such complex geometries (see
[16]). Such models have emerged in the recent past, though none of these models
has integrated all aspects of the rheological behavior of blood in a single unifying
framework.
Mathematical modeling of the hemostatic mechanism has become increasingly
important in recent years as a useful supplement to experimental data, and as a
means for systematically quantifying the various biochemical factors involved in the
formation and dissolution of clots. A mathematical model of the in-vitro formation
and dissolution of clots would be especially useful in confirming or even interpreting
the results from laboratory tests like the PT and the aPTT. Although many math-
ematical models have been posited for various sets of reactions that are involved in
the enzyme cascade of coagulation, none has been developed that puts together the
entire sequence of events from clot formation till dissolution (i.e. platelet activation,
coagulation, and fibrinolysis). Such a model, once corroborated with existing exper-
imental data, would be of immense value in making predictions with clear clinical
correlations.
Constitutive modeling of (the various types of) clots is of importance when one
tries to understand the role of flow and shear stresses during clot formation and
rupture. Development of models predictive of clot mechanical behavior, will allow
for testing of the effects of various biochemical and local hemodynamic alterations on
thrombus hemostatic function. A rheological model of clot formation can also be used
to generate tissue sealants or biological “glues (used, in the clinical setting, to effect
optimal hemostasis) with ideal biochemical compositions and resultant mechanical
8properties. Reliable rheological models for clots are sparse in the literature, apart
from being largely simplified at present, and a rigorous model that could be used in
three-dimensional flow situations where clot formation is suspected, or encountered,
would be of importance.
A set of models that could be used to predict regions susceptible to clot formation,
track the extent of clotting, once initiated, and, if applicable, predict its dissolution
or an embolism would be of immense value to engineers seeking to minimize such an
occurence within a cardiovascular device. There is a need to develop models that can
help us understand the interplay of the rheological and biochemical factors under the
diverse flow conditions found in the human vasculature. Such models are in their
infancy at present, tending to focus on single aspects of this multifaceted problem,
and an integrated model is yet to emerge that incorporates all these factors in a
physiologically accurate scheme.
D. Specific aims of dissertation and organization
In this dissertation, a framework is developed for the elucidation of Virchow’s triad;
each component of this framework is corroborated with the appropriate experimental
data and their predictions checked for reliability and clinical relevance. The entire
framework is tested in some simple flow problems, and the results from these calcu-
lations are discussed.
A model is developed for describing the flow of human blood; the model is ca-
pable of describing the shear-thinning and viscoelastic fluid-like behavior (with a
deformation-dependent relaxation time) of blood, and arises in a thermodynamic set-
ting that recognises that viscoelastic fluids possess multiple natural configurations.
The model is corroborated with data for apparent viscosity, and oscillatory flow in
9small diameter tubes. The model predictions for flow reversals when blood is subject
to pulsatile pressure gradients in a rigid-walled pipe tie in nicely with observations on
the deformation-dependent viscoelastic behavior of blood, and the model predictions
of negligible first normal stress differences tie in with experimental observations.
A mathematical model consisting in a set of convection-diffusion-reaction equa-
tions is used to simulate the transport and the biochemical changes in flowing human
blood of the various reactants involved in platelet activation, (the extrinsic and in-
trinsic pathways of) coagulation, and fibrinolysis. The growth and dissolution of
the clot that is formed is governed by the boundary conditions that govern the sur-
face concentration of TF-VIIa, the generation of XIa via the intrinsic pathhway, the
extent of platelet-subendothelium interaction, and the secretion of tPA due to en-
dothelial activation. The model is corroborated with data for clot formation, and for
clot dissolution, in quiescent human plasma (this involves only the reaction-diffusion
equations), and its predictions for the severity of Antithrombin-III deficiency over
Protein-C deficiency offer an insight into clinical observations.
A model is developed for describing the flow of a certain kind of clot formed from
human plasma that is most likely to occur under normal physiological conditions; the
model is capable of describing the viscoelastic-fluid like behavior of the clot, and its
predictions for the apparent viscosity that would be inferred from the clot are in
keeping with the physical expectation that the clot be more viscous than the plasma
from which it is formed.
The framework of models is applied to three simple flow problems that are rep-
resentative of some conditions encountered in the vasculature, and the results from
the solution of two of these problems are analyzed. The results for clot formation
and dissolution in quiescent plasma on a thrombogenic plane are obtained. The equa-
tions for the case of time-varying poiseuille-type flow are developed but they are not
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solved. A system of models consisting of two shear-thinning viscoelastic liquids and
a simple activation criterion allowing a switch between the model for liquid prior to
activation (Blood) and the liquid after activation (Clot: which is more viscous than
blood) in the context of oscillatory flow in an infinitely long rigid-walled cylindrical
pipe is studied, and the simulations reveal qualitative insights into the phenomenon
of clot formation in flowing blood.
A model that accounts for the rheology of blood and the clot while at the same
time incorporating the basic reactions of platelet activation, the extrinsic and intrinsic
coagulation pathways, and fibrinolysis and allowing for surface modulation of these
reactions is presented. Clot formation and dissolution in flowing blood is viewed as
a moving boundary problem involving two viscoelastic liquids; the dynamics of the
interface is governed by both mechanical and biochemical factors. This is but a first
step in the direction of modeling and understanding the problem of clot formation
and dissolution in flowing blood.
An accurate mathematical model requires a proper understanding of the myriad
of factors that play a role in the formation and dissolution of clots, and hence the
relevant rheological, biochemical, and medical issues are discussed (or appropriate
references given) in some length at each stage in the assembly of the framework.
The key concepts (and the relevant mathematical notation) employed in the
rest of this dissertation are outlined in Chapter 2. A shear-thinning viscoelastic
fluid model with a deformation-dependent relaxation time for describing the flow of
blood is developed, and tested in Chapter 3. A mathematical model for studying the
formation and dissolution of clots is developed and tested (for quiescent plasma in
the in-vitro setting) in Chapter 4. A viscoelastic fluid model for describing the flow
of a particular type of plasma clot is developed and tested in Chapter 5. The results
for clot formation and dissolution on a thrombogenic surface in quiescent plasma (in-
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vitro) are reviewed, the equations relevant to time-varying poiseuille-type flow with
clot formation in a cylindrical annular region are presented, and the entire framework
of models is applied to some simple flow problems in Chapter 6; a summary of the
results is given, and, in concluding, suggestions that could be taken up for future
study are made.
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CHAPTER II
PRELIMINARIES
The notation involved in the development of constitutive models for viscoelastic flu-
ids (with multiple natural configurations) is reviewed. The notation is encountered
when the models for describing the flow of blood and the flow of the plasma clot
are presented. The form of the convection-diffusion-reaction equations that are used
in the mathematical model for describing the formation and dissolution of clots in
flowing blood is then outlined; these equations govern the movement and biochemical
changes of the various constituents involved in hemostasis which are assumed to exist
at every point in the domain whether the domain be occupied by blood or clot at
any given instant in time. The balance equations encountered in applying the set of
models to simple flow problems are then outlined.
A. Constitutive models for viscoelastic fluids of the rate-type
The framework for the development of the constitutive theory for viscoelastic fluids
(possessing multiple natural configurations) has been outlined in [81], and the nota-
tion introduced therein is adhered to here. Let κR(B) and κt(B) denote the reference
and the current configuration of the body B at time t, respectively. Let κp(t)(B)
denote the stress-free configuration that is reached by instantaneously unloading the
body which is at the configuration κt(B) (Figure 2). As the body continues to de-
form these natural configurations κp(t)(B) can change (the suffix p(t) is used in order
to highlight that it is the preferred stress free state corresponding to the deformed
configuration at time t. See Rajagopal [80] for a detailed discussion of the notion of
natural configurations).
By the motion of a body we mean a one to one mapping that assigns to each
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κR(B)
FκR
κt(B)
Fκp(t)
κp(t)(B)
G
X x
Fig. 2. Schematic of the natural configurations associated with a viscoelastic fluid
having a single relaxation mechanism, and capable of instantaneous elastic
response.
point X ∈ κR(B), a point x ∈ κt(B), for each t, i.e,
x = χκR(XκR, t). (2.1)
We assume that the motion is sufficiently smooth and invertible. We shall, for the
sake of convenience, suppress B in the notation κR(B), etc.
The deformation gradients, FκR , and the left and right Cauchy-Green stretch
tensors, BκR and CκR, are defined through:
FκR =
∂χκR
∂XκR
, BκR = FκRF
T
κR
, and CκR = F
T
κR
FκR . (2.2)
The left Cauchy-Green stretch tensor associated with the instantaneous elastic re-
sponse from the natural configuration κp(t) is defined in like fashion:
Bκp(t) = Fκp(t)F
T
κp(t)
. (2.3)
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The principal invariants of Bκp(t) are
IB = tr(Bκp(t)), IIB =
1
2
{
[tr(Bκp(t))]
2 − tr(B2κp(t))
}
, and IIIB = det(Bκp(t)) . (2.4)
For homogeneous deformations, Fκp(t) denotes the deformation gradient between the
natural configuration and the current configuration. The mapping G is defined
through:
G = FκR→κp(t) = F
−1
κp(t)
FκR . (2.5)
The velocity gradients, L and Lκp(t), are defined through
L := F˙κRF
−1
κR
and Lκp(t) = G˙G
−1 , (2.6)
where the dot signifies the material time derivative.
The symmetric parts of L and Lκp(t), are defined through
D =
1
2
(L+ LT ) and Dκp(t) =
1
2
(Lκp(t) + L
T
κp(t)
). (2.7)
The upper convected Oldroyd derivative of Bκp(t),
5
Bκp(t), is given through
5
Bκp(t)= B˙κp(t) − LBκp(t) −Bκp(t)L
T = −2Fκp(t)Dκp(t)F
T
κp(t)
. (2.8)
As we shall assume that the fluid (whether blood or plasma clot) is incompress-
ible, we shall require that
tr(D) = 0 , (2.9)
and
tr(Dκp(t)) = 0 . (2.10)
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1. Maximization of the rate of dissipation assumption
The procedure for obtaining models of the rate-type is outlined in [81], and models
due to Maxwell, Oldroyd and Burgers are special models within this framework.
The models arise in a thermodynamic setting that involves specifying the manner
of the rate of dissipation and the manner in which energy is stored by the material
in question. The procedure also guarantees constitutive relations that automatically
meet the second law of thermodynamics.
The second law of thermodynamics is used in the following form:
T ·D− ρψ˙ − ρηθ˙ −
q · gradθ
θ
= ρθζ = ξ , (2.11)
and ζ ≥ 0, or equivalently ξ ≥ 0, is enforced. Here T is the stress tensor, D is
the stretching tensor, ψ is the specific Helmholtz potential, η is the entropy, θ is
the temperature, ζ is the rate of entropy production, and ξ is the rate of dissipation
(which usually refers to the amount of working converted into “heat” or energy in
thermal form).
The rate of dissipation is ensured to be non-negative, and the rate of dissipation
is maximized to select the final constitutive equation. The salient feature of this
approach is that we do not appeal to a procedure that is often used to place restrictions
on allowable constitutive relations that presumes that the body can be subject to
arbitrary processes (see [82] for a detailed discussion of these issues).
A brief sketch of the procedure to obtain the final constitutive equation, for a
material subject to isothermal processes, is given below; further details are found in
[81].
The rate of dissipation associated of the material, subject to isothermal processes,
16
is given by
ξ = T ·D− W˙ . (2.12)
We make constitutive assumptions for the stored energy W , and rate of dissipa-
tion ξ for the material (a viscoelastic fluid), and assume that
W = Wˆ (IB, IIB) , (2.13)
and
ξ = ξˆ(Bκp(t),Dκp(t)) . (2.14)
We also stipulate that ξˆ(·, 0) = 0.
On differentiating Equation (2.13) with respect to time, we obtain
W˙ =
(
α01 + α1Bκp(t)
)
· B˙κp(t), (2.15)
where α0 = (
∂Wˆ
∂IB
) and α1 = 2(
∂Wˆ
∂IIB
). It can now be shown that
W˙ = 2
(
α0Bκp(t) + α1B
2
κp(t)
)
·
(
D−Dκp(t)
)
. (2.16)
Substituting from Equation (2.16) in Equation (2.12), and using Equation (2.14)
and the fact that only isochoric motions are allowed, we can stipulate the stress tensor
as
T = −p1 + 2
(
α0Bκp(t) + α1B
2
κp(t)
)
. (2.17)
We also obtain that
ξ = T ·Dκp(t) . (2.18)
The constrained maximization procedure involves extremizing ξ subject to con-
straints (Equations (2.10) and (2.18)), leading to the following equation for Dκp(t):
T− λ1
∂ξˆ
∂Dκp(t)
− λ21 = 0 , (2.19)
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where λ1 and λ2 are Lagrange multipliers whose values are obtained by the satisfaction
of the constraints (Equations (2.10) and (2.18)).
The procedure outlined above, along with specific choices for the stored energy
function and the rate of dissipation, will now yield the appropriate rate-type model.
B. Convection-diffusion-reaction equations
The equations governing the flow and generation/depletion of the various constituents
are all of the following form:
∂[Yi]
∂t
+ div([Yi]v) = div(DYi(D)∇[Yi]) +GYi; i = 1, ..., 25. (2.20)
Here, and elsewhere below, [Yi] represents the concentration of the reactant Yi, GYi
represents the production or depletion of Yi due to the enzymatic reactions, v is
the velocity field, and DYi represents the diffusion coefficient of Yi which could be a
function of the shear rate (captured by means of the stretching tensor D).
These constituents are assumed to co-exist at every point in the domain, and
that, being of an extremely small composition, they do not affect the velocity of the
bulk flow. The framework for studying the reaction-diffusion equations coupled with
the flow equations is such that it allows a natural extension into a mixture theory
model should the need arise.
C. Balance equations
The equations for the balance of mass, linear momentum, angular momentum, and
internal energy are:
Dρ
Dt
+ ρdivv = 0 , (2.21)
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divT+ ρb = ρ
Dv
Dt
, (2.22)
T = TT , (2.23)
ρ˙ = T ·D+ ρΓ− divq . (2.24)
Equation 2.23 is a statement of the balance of angular momentum in the absence of
internal body forces. Here ρ is the density, v is the velocity field, T is the stress
tensor,  is the specific internal energy of the material, D is the stretching tensor, q
is the heat flux, and Γ is the energy influx due to radiation.
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CHAPTER III
BLOOD∗
Blood exhibits non-Newtonian rheological behavior like shear-thinning properties
and stress-relaxation behavior. A shear-thinning, viscoelastic fluid model with a
deformation-dependent relaxation time is developed, and the efficacy of this model
for describing the flow of human blood is tested. The model emerges in a hierarchy of
nonsimple viscoelastic fluid models developed in a thermodynamic framework. The
framework within which the model is developed leads to blood being characterised by
four independent parameters that reflect the formation of rouleaux and its effect on
the viscosity of blood, the shear thinning that takes place during the flow, the elastic-
ity attributed to the RBC membrane, and the viscosity of the plasma. The model is
corroborated with data from steady flow experiments (that report apparent viscosity)
and oscillatory flow experiments. The model is then used to make predictions for the
flow reversals when a pulsatile pressure gradient is applied to blood in a rigid-walled
cylindrical tube, and also for the first normal stress differences, and these predictions
are in keeping with physical expectations and match experimental data, respectively.
A. Composition and rheological behavior
Whole blood consists of gel-like ‘cell’ matter in an aqueous plasma solution. The cell
matter (which makes up around 46% of the volume in male human blood) consists of
formed elements: primarily (around 98%) Red Blood Cells (RBCs) or erythrocytes,
White Blood Cells (WBCs) or leukocytes, and platelets. The volume concentration
of RBCs in whole blood is termed hematocrit. Plasma consists primarily in water
∗Part of the material presented in this chapter is reprinted with permission from
[5]. Copyright 2004 by International Journal of Cardiovascular Medicine and Science.
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(92%-93%) in which various proteins (f-I or fibrinogen, f-II or prothrombin, f-V, f-
VIII, f-IX, f-X, f-XI, f-XII, f-XIII, antithrombin-III, tissue-factor pathway inhibitor,
protein C, protein S, plasminogen, α1-antitrypsin, α2-antiplasmin, etc.) are dissolved
along with various ions (sodium (Na+), potassium (K+), calcium (Ca2+), magnesium
(Mg2+), chloride (Cl−), bicarbonate (HCO−3 ), phosphate (PO
3−
4 ), etc.). Plasma is
a Newtonian liquid with a viscosity of approximately 1.2 cP [26]. Erythrocytes are
biconcave deformable discs with no nuclei. The RBC membrane comprises 3% by
weight of the entire RBC and consists of proteins (spectrin) and lipids. The RBC
cytoplasm is a solution of hemoglobin in water (32g/100ml). Evans and Hochmuth
[34] performed micropipette aspiration expirements which showed that RBCs display
viscoelastic behavior. They also claimed that the viscoelastic nature of the RBC is
only due to the viscoelastic properties of the RBC membrane. The leukocytes are
classified as the granulocytes, the monocytes and the lymphocytes, and form less than
1% of the volume of blood. Their influence on the rheology of blood is not consid-
ered to be significant except in extremely small vessels like capillaries. Granulocytes
exhibit viscoelastic properties [89] in micropipette aspiration experiments. Thus, the
various constituents of blood exhibit different rheological properties.
The shear-thinning properties ([20],[26]) and stress-relaxation behavior ([96]) of
whole blood are well known. The shear-thinning nature of blood has been tied to the
disaggregation of the RBC-rouleaux aggregates that form at low shear (see Figure
3) and the deformability of the RBCs [24],[25], while its stress-relaxation properties
are tied to the viscoelastic nature of the RBC membrane [34], [23] (see [101], [102]
for a visualization of the microstructural changes that occur when blood is subject
to oscillatory and steady shearing flow). The viscoelastic behavior of blood is less
prominent at higher shear rates [97].
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Fig. 3. Disaggregation of RBC-rouleaux aggregates upon application of steady shear
flow. Reprinted from [112] with permission from IOS Press.
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B. Literature survey of models
1. Continuum models
One of the early attempts to model blood as a continuum, with a yield stress, involved
adapting the Casson’s model for ink proposed in 1958 [19]. This model holds only
for 1 dimensional flow situations, and can be used, at best, for fluid flow in axisym-
metric rigid pipes. Continuum models have evolved, since then, to incorporate both
the shear-thinning and viscoelastic behaviour of blood, and their dependence on the
evolution of the underlying microstructure (the break-up and rearrangement of the
rouleaux).
The Cross [30] and the Walburn and Schneck [116] models are among the earliest
shear-thinning models, but can be used only in one-dimensional flow situations. A
review of the various one-dimensional shear-thinning models with the myriad expres-
sions for the apparent viscosity can be found in [27].
Phillips and Deutsch [77] proposed a four constant Oldroyd-B type of model that
captured the rheological behavior of blood reasonably well. Thurston was among the
earliest to attempt to incorporate the viscoelastic nature and the shear-thinning be-
havior of blood in a single model, and proposed an extended Maxwell model [100].
This model applies only in 1-D flow situations. Quemada [79] proposed a non-linear
Maxwell model with an evolving internal variable (structural parameter) that under-
lies the change in viscosity with shear rate, and a similar generalization of the Maxwell
model was proposed by Sharp and coworkers [91]. These models, like the ones pro-
posed by Vlastos and coworkers [114], [115], are applicable only for one-dimensional
flow situations.
Yeleswarapu [122] proposed a generalization of a three constant Oldroyd-B model
that was an improvement over earlier three-dimensional viscoelastic models (see [122]
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for a detailed literature survey of three-dimensional continuum models for blood flow),
and captured the shear-thinning behavior of blood over very large shear rates.. Sun
and De Kee [94] proposed a generalized Maxwell model for blood with an internal
variable to capture the shear-thinning behavior. Their model has more parameters
than the Yeleswarapu model and, like the Yeleswarapu model, has its limitations
given that the relaxation times do not depend on the shear rate, a dependence that
can be gleaned from experiments.
2. Dilute suspension, two-fluid, and mixture theory models
Kline and coworkers were among the earliest to propose that models of fluid suspen-
sions be applied to blood flow. These models assume either that RBC deformations
are negligible [53], or that RBC-RBC interactions and RBC-artery wall interactions
are negligible [52], and do not have a sound physical basis in the light of what is
currently known about RBC interactions during blood flow. Chaturani and cowork-
ers proposed two fluid models for blood flow in small arteries [22], [21] based on the
experimental observations of a erythrocyte rich core surrounded by a layer of plasma
for flow in rigid walled small tubes. However, these models are valid only for small
arterioles, and are not adequate for large arteries.
Trowbridge (1984) [105] proposed a model for blood as a binary mixture of
erythrocytes and plasma. The model predicted a Newtonian behavior for the mixture
and cannot, per se, be used to model blood.
C. A shear-thinning viscoelastic fluid model for blood
Whole blood is modeled as a shear-thinning viscoelastic fluid continuum with a de-
formation dependent relaxation time. The properties of this continuum are assumed
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to depend on, and regulated by the various biochemical processes that take place and
this is reflected in the basic balance laws for the continuum being coupled to and
augmented by a system of convection-diffusion-reaction equations.
1. Constitutive assumptions
The rate of dissipation ξ associated of the material is defined through
ξ = T ·D− W˙ . (3.1)
The form chosen for the rate of dissipation in this study is
ξ = αb
(
Dκp(t) ·Bκp(t)Dκp(t)
)γb
+ ηb1D ·D. (3.2)
This form for the rate of dissipation corresponds to a mixture of a viscoelastic fluid
that has a power-law viscosity (a generalized Maxwell fluid) and a Newtonian fluid.
Such a choice is particularly appropriate as blood is a mixture of a Newtonian fluid
(plasma) and the other constituents such as cells are elastic membranes containing
fluids. The RBC-based microstructure evolves upon the application of shear, the
evolution at a particular shear rate depending on the type of rouleau formed (at
that shear rate), and becomes progressively liquid-like. While treating blood as a
single continuum, we may thus include the entropy production due to the various
mechanisms (viscous dissipation and disaggregation of rouleau structures). As a first
step, it is assumed that these mechanisms are not interrelated. Additionally, it is
assumed that the rate of dissipation is non-negative (α, η1 > 0) satisfying the second
law.
The Helmholtz potential associated with the elastic response is assumed to be
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that of a neo-Hookean material 1:
W ≡ ρψ =
µb
2
(
IB − 3
)
. (3.3)
Following the procedure of constrained maximisation outlined earlier, the follow-
ing model is obtained (Equations (3.4)-(3.8)) 2:
T = −p1 + S , (3.4)
S = µbBκp(t) + η
b
1D , (3.5)
B
∇
κp(t) = −2
(
µb
αb
)1+2nb(
tr(Bκp(t))− 3λ
)nb[
Bκp(t) − λ1
]
, (3.6)
λ =
3
tr(B−1κp(t))
, (3.7)
nb =
γb − 1
1− 2γb
; nb > 0. (3.8)
The relaxation time governing the evolution ofBκp(t) is
[
2
(
µb
αb
)1+2nb(
tr(Bκp(t))−
3λ
)nb]−1
, and is dependent on the elastic stretch. In like fashion, as the shear rate
varies, the underlying rouleau size varies as does the corresponding relaxation time.
However the relaxation time and the apparent viscosity (as seen from the equations
that will be developed shortly) tend to ∞ as D→ 0 (as shear rate tends to zero).
In order to ensure that the zero-shear viscosity is finite, a Heaviside function is
introduced into the expressions for the viscosity and shear thinning index,
αb = αbfH(IB − I
b
0) + α
b
0
(
1− H(IB − I
b
0)
)
, (3.9)
1This choice corresponds to that for an isotropic material. However, directional
effects may come into play due to the evolution of the rouleaux formations with the
application of shear; a discussion of the issues underlying the choice of the Helmholtz
potential can be found in [5].
2This model is not capable of an instantaneous elastic response. See discussion in
[81].
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γb = γbH(IB − I
b
0) +
(
1− H(IB − I
b
0)
)
, (3.10)
αb0 = 2(η
b
0 − η
b
∞) , (3.11)
where ηb0, η
b
∞ are the asymptotic viscosities of blood at low and high shear rates, and
I0 is a suitably chosen constant. The notation
K
b =
(
µb
αb
)1+2nb
, (3.12)
is introduced for the sake of convenience.
D. Model corroboration
The parameters Kb, µb, nb and ηb1, that are used in defining the model (Equations
(3.4)-(3.8)) are determined so that the best fit is obtained for both steady flow data
reporting apparent viscosity [122] and oscillatory flow data [98] of human blood 3.
The model is treated without reference to the detail in Equations (3.9)-(3.12). This
is a minor detail, and can be fixed.
1. Apparent viscosity
Data for the apparent viscosity is reported from measurements in the rotating cylinder
rheometer [122]. The material constants are inferred from measurements of torque and
shear rate. Most commercial cylindrical rheometers (like the one used to obtain the
data in [122]) employ a data reduction procedure based on a “small gap” assumption
(see [118]). These approximate the shear rate at the wall by a constant mean value
assuming that the variation of shear rate across the gap is small. The validity of such
3The model has also been used (with a different set of parameters) to match data
for steady Poiseuille flow of porcine blood in rigid walled tubes [124], and the details
can be found in [5]
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an assumption is questionable for non-Newtonian liquids (see Yeleswarapu [122] for
a brief parametric study of his model in such a flow situation). However, we proceed
by assuming that the measured shear rate is a good approximation to the wall shear
rate. It is preferable to use data (if available) reporting measured torques (or wall
shear stresses) and angular speeds so that the intervening approximations may be
reduced, and the material parameters may be fixed with greater precision. Data in
the literature that has been reviewed is reported as apparent viscosity, though.
The flow field between the cylinders is assumed to be of the following form:
v = u(r)eˆθ = rw(r)eˆθ (3.13)
Substituting the constitutive equations (3.4)-(18) in the equations for balance of linear
momentum and assuming an axisymmetric two dimensional stress field, the following
expression is obtained for the wall shear stress (from which the torque is calculated):
Trθ =
( µbλ
χ
+ ηb1
2
)(
du
dr
−
u
r
)
. (3.14)
Assuming that the shear rate is nearly constant across the gap (“thin gap as-
sumption”), we obtain:
du
dr
−
u
r
= Ro
∆w
δr
, (3.15)
where Ro is the radius of the outer cylinder, ∆w is the difference in angular velocity
between the outer and inner rotating cylinders, and δr represents the gap between
the cylinders. The apparent viscosity reported for the model, given the torque and
the shear rate, is:
µapp =
µbλ
χ
+ ηb1
2
, (3.16)
where λ is determined using the incompressibility condition: det(Bκp(t)) = 1, and it
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is given by:
λ =
1[
1 + 1
4χ2
(du
dr
− u
r
)2
]1/3 . (3.17)
At any given shear rate, χ is obtained by solving:
χ = Kb
[
2γ˙2meas
4χ2
1
(1 + γ˙
2
meas
4χ2
)1/3
]n
, (3.18)
where
γ˙meas = (
du
dr
−
u
r
) . (3.19)
All four parameters are fixed using the expressions in Equations (3.16),(3.17),(3.18).
For the limit γ˙meas → 0, λ\χ→∞, but this can be fixed using Equations (3.9)-(3.12).
For the limit γ˙meas → ∞, λ\χ = 0 and η1 = 2η∞. The multidimensional uncon-
strained minimisation procedure in MATLAB (fminsearch) is used to fix K, µ and n
for the best fit, with χ being solved by the fzero routine in MATLAB. The constants
obtained (for human blood, ηb0 = 0.0736Pa.s , η
b
∞ = 0.005Pa.s) are K
b = 58.0725s−1,
µb = 0.1611N/m2, nb = 0.5859 (n must be positive to ensure shear-thinning behav-
ior), and ηb1 = 0.01Pa.s, and are but one among a very large selection that can fit
the data equally well. The proposed model fits the experimental data better than the
model proposed by Yeleswarapu at shear rates higher than 1 sec−1 (Figure 4).
2. Application to oscillatory flow
The model parameters are fixed so that the amplitude of and phase difference between
the pressure gradient and volume flow rate for oscillatory flow in a rigid-walled pipe
obtained by numerical simulations matches the experimental data for a set of cases.
This procedure is essential to validate the model over the gamut of flow conditions
that are expected in the human vasculature. The set of experimental data that is
used is just one among several sets of data available to infer the viscoelastic nature
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Fig. 4. Apparent viscosity of human blood. Predictions (of µapp) from the proposed
model, and the Yeleswarapu model are compared with the data [122].
of blood, and the model can be used to match these sets of data as well (for instance,
the model can be used to match the stress-relaxation data in [68]).
Experimental data for the pressure gradient and volume flow (and the phase
difference between them) under conditions of oscillatory and pulsatile flow through
small tubes is available in [98] and [99]. The pressure gradient in phase with the
volume flow rate (P ′), and the component in quadrature with the volume flow rate
(P ′′) are measured along with the (amplitude of) volume flow rate, and these are
used to infer the values of the complex compliances (η′,η′′; see [117], [118] for an
explanation of these quantities and a list of other experimental protocols by which
they may be inferred). Such a data reduction procedure is not correct, given that
we are dealing with a non-linear viscoelastic fluid; the pressure gradient and volume
flow rate values from the numerical simulations are thus compared with the values of
pressure gradient and volume flow rate reported in [98].
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We seek a solution for oscillatory flow in a pipe of the form:
v = u(r, t)eˆz , p = p(r, z, t). (3.20)
A time periodic solution is sought for v, given the time periodicity of the imposed
pressure gradient:
−
1
ρb
∂p
∂z
= Acos(wt) . (3.21)
Upon substituting Equations (3.20),(3.21) into the balance of linear momentum, and
assuming that the components of the stress depend only on the radial coordinate, the
following equations are obtained (in non-dimensional form):
∂u∗
∂t∗
= −
∂p∗
∂z∗
+
S∗rz
r∗
+
∂S∗rz
∂r∗
, (3.22)
∂Brz
∂t∗
=
∂u∗
∂r∗
Brr − 2χ(Bκp(t))
R
Ve
Brz , (3.23)
∂Brr
∂t∗
= 2χ(Bκp(t))
R
Ve
(λ− Brr) , (3.24)
∂Bzz
∂t∗
= 2
∂u∗
∂r∗
Brz + 2χ(Bκp(t))
R
Ve
(λ−Bzz) , (3.25)
where
S∗rz =
µb
ρbVe2
Brz +
ηb1
2ρbRVe
∂u∗
∂r∗
, (3.26)
λ =
3Brr(BrrBzz − B
2
rz)
B2rr + 2BrrBzz − B
2
rz
, (3.27)
χ(Bκp(t)) = K
b
(
2Brr +Bzz − 3λ
)nb
, (3.28)
and R, Ve are the pipe radius and characteristic velocity respectively. (Note: Bθθ =
Brr, Brθ = Bθz = 0).
The non-dimensionalisation is as follows: t∗ = tVe/R, w∗ = wR/Ve, u∗ = u/Ve,
r∗ = r/R, z∗ = z/R, S∗rz = Srz/ρVe
2, p∗ = p/ρVe2, and A∗ = AR/Ve2.
The above PDEs are solved over the domain 0<r<1, for t≥ 0, subject to the
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following boundary condition:
u∗(1, t) = 0 , (3.29)
and center-line condition:
∂u∗(0, t)
∂r∗
= 0 . (3.30)
The exact solution for pulsatile flow of a Newtonian fluid [101] is set as the initial
condition, whereas Bκp(t) = 1 is used as an initial guess for the components Brz, Brr,
Bzz.
A predictor-corrector type numerical approach is used to solve the equations.
The (coupled) PDEs are decoupled from each other, and the PDE for the velocity is
treated as an IBVP, while the others are treated as IVPs. The coupling is brought
about by means of an iterative process at each time step. The absence of the spatial
derivative for Brz, etc., (the components of Bκp(t)) in the appropriate equations,
implies that it is enough to fix the boundary conditions for the velocity. Once the
velocity is obtained, the values of the components of Bκp(t) can be obtained over the
entire domain (0≤r≤1).
The numerical simulations are performed (ρb = 1053.6kg/m3, Ve = 1cm/sec)
for a pipe of radius, R = 0.43 mm, at a frequency, f = 2Hz, in like manner to the
experiments. The results of the simulation for a set of parameters that also fit the
apparent viscosity data exceptionally well are given in Figure 5. The fit shown can be
made better through better optimisation procedures, but such elaborate techniques
are not adopted given the convergence characteristics of the numerical procedures.
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Fig. 5. Pressure (gradient) components in phase, P ′, and in quadrature, P ′′, with (am-
plitude of) volume flow rate for oscillatory flow of human blood in a rigid-walled
pipe. The predictions of the proposed model (Kb = 1.2056s−1, µb = 0.0227
N/m2, nb = 0.7525, and ηb1 = 0.01Pa.s), are compared with data [98].
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E. Physical relevance of model predictions
The model predictions are obtained for flow in a rigid-walled pipe with a pulsatile
pressure gradient of the form:
−
1
ρ
∂p
∂z
= A(1 + cos(wt)) , (3.31)
being applied.
The model predicts flow reversals, with the (relative) magnitude of flow reversal
decreasing with increasing amplitude of the pressure gradient (Figure 6). This is a
corroboration of the experimental evidence that the elastic properties of blood become
less prominent with an increase in shear rate; inertial effects being more important
at higher shear rates, and elastic effects dominating at low shear rates. It would be
interesting to demonstrate this experimentally and to report the actual extent of flow
reversal. However, no such data is available at the moment.
Copley and King [29] have reported measurements that show that blood mani-
fests negligible normal stress differences during flow, and this observation is corrob-
orated by the predictions of the first normal stress difference coefficient (ψ1) by the
model which (along with the predictions of the Yeleswarapu model) shows a steep
drop in the normal stress difference at shear rates above 1 sec−1 (Figure 7). Precise
numbers are not available, but, if such data is found, the model predictions for ψ1
(ψM1 for the proposed model, and ψ
Y
1 for the Yeleswarapu model) should be compared
for quantitative accuracy.
ψM1 =
(Szz − Srr)
γ˙2meas
=
µbλ
2χ2
(3.32)
ψY1 =
(Szz − Srr)
γ˙2meas
= 2
(
ν(γ˙meas)λ1 − η0λ2
)
(3.33)
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CHAPTER IV
THE FORMATION AND DISSOLUTION OF CLOTS∗
The formation and dissolution of clots in flowing blood is a complex phenomenon
involving several biochemical and rheological changes that involve the components of
blood, the flow regimes prevalent in the concerned region of the vasculature, and the
surface of the vessel. A mathematical model consisting in a set of coupled convection-
diffusion-reaction equations is developed to simulate the transport and biochemical
changes of 25 consituents (present in human blood) that are essential to a complete,
if not comprehensive, understanding of the phenomenon. The model (the reaction-
diffusion equations) is corroborated with data for the formation and growth of a
clot in quiescent platelet-poor plasma, and also with data for the dissolution of a
formed clot in quiescent conditions. The entire set of equations is used to predict the
consequences of Antithrombin-III (AT-III) deficiency and Protein-C (PC) deficiency,
and the predictions match clinical data for the extreme severity of AT-III deficiency
over PC deficiency.
A. Biochemical and rheological changes accompanying hemostasis
Two important interacting processes, platelet activation followed by adhesion and
aggregation, and coagulation, are initiated when there is an imbalance in favor of
pro-thrombotic factors in flowing blood. This occurs in response to a variety of
stimuli; an injury in the vessel wall, for instance, or contact with an exogenous foreign
surface like glass, or imbalances between pro- and anti-thrombotic factors in the intact
∗Part of the material presented in this chapter is reprinted with permission from
[2]. Copyright 2003 by Taylor and Francis Ltd (http://www.tandf.co.uk). Part of the
material in this chapter will be incorporated in an article that is in preparation [3].
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endothelium itself (“Endothelial dysfunction” [40]), or due to certain flow conditions
like stagnation and recirculation zones. The activated platelets that are generated
can form aggregates by binding to each other and to fibrin, a stringy polymeric
molecule formed at the end of the coagulation reactions. Coagulation involves a
core cascade of enzymatic reactions [63], [31] involving plasma zymogens, anionic
phoshpholipids on the membranes of activated platelets, and calcium ions resulting,
ultimately, in the formation of thrombin from prothrombin, and then the cleavage
of fibrinogen to yield fibrin. The platelet aggregates along with the fibrin mesh
constitute the blood clot, and their formation comprises haemostasis, the normal
response to vessel injury. Fibrin, along with other intermediates of the coagulation
pathway and enzymes produced by endothelial cells, catalyze and participate in a set
of reactions (fibrinolysis) that lead to the conversion of plasminogen to plasmin, thus
initiating clot dissolution. This broad picture (see Figure 8) includes multiple positive
and negative feedback loops and regulatory processes that involve the molecules in
blood, its flow and the surface of the vessel (Virchow’s triad). It is crucial that these
processes act in a controlled fashion for the maintenance of vascular integrity without
significant impairment to the flow of blood. A brief review of the main components
and processes involved in the formation, development and dissolution of clots that
will be incorporated in the model is given below; additional details and references can
be found in [2].
1. Platelet activation, adhesion and aggregation
Platelets form a small fraction (by volume) of the particulate matter in human blood
(around 3%). They are among the most sensitive of all the components of blood
to chemical and physical agents [58]. Platelets are small discoid cell fragments, ap-
proximately 6µm3 in volume, derived from megakaryocytes. Platelet activation is the
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of clots.
process by which the resting discoid platelet undergoes a series of chemical and mor-
phological changes as a result of which the organelles within the platelet are central-
ized, glycoproteins on the platelet membrane undergo a change in conformation, and
long pseudopods are extended so that the activated platelet is a sticky spiny sphere.
Platelet activation occurs due to interaction with collagens and adhesive glycopro-
teins exposed by rupture of the subendothelium, for instance, or due to interaction
with thrombin or adenosine diphosphate (ADP) that circulate in the blood. Platelet
activation is followed by interaction with plasma proteins like Factor-IX (IX), Factor-
V (V), and vWF, fibrinogen, and fibrin so as to adhere to sub-endothelial tissue, form
platelet aggregates, and ultimately form a clot. Activated platelets also release f-XIII,
which through activation by thrombin, forms f-XIIIa that cross-links and stabilizes
the fibrin matrix binding the clot. The rate and extent of platelet adhesion, platelet
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deposition and platelet thrombus (or mural thrombus) formation are affected by the
flow conditions (shear rates) [111]. Platelet activation itself [56], and sometimes ly-
sis, is known to occur in response to prolonged exposure to high shear stresses [121].
Platelet aggregates, by themselves and as part of clots, are susceptible to break-up
by high shear stresses [120], [85]. There are, thus, both biochemical changes and
rheological influences during platelet activation, adhesion and aggregation.
2. Extrinsic and Intrinsic pathways of coagulation
The extrinsic coagulation pathway is particularly important in the context of vessel
wall injury. The exposure of tissue-factor (TF) (a cell membrane bound protein)
in the subendothelium to the mainstream blood flow results in a chain of coagula-
tion reactions (the extrinsic pathway) that lead to the formation of thrombin, an
enzyme that catalyzes fibrin production and a very important enzyme for platelet
activation. It is generally accepted that the formation of the TF-VIIa complex on the
subendothelium leads to the formation of the enzymes, Factor-IXa (IXa) and Factor-
Xa (Xa), both of which are serine proteases, from the respective plasma zymogens
(enzyme antecedents), Factor-IX (IX) and Factor-X (X), after the cleavage of the
prosequences. These enzymes, in turn, catalyze the formation of Factor-Va (Va) and
Factor-VIIIa (VIIIa) from Factor-V (V) and Factor-VIII (VIII), respectively. The
cascade of reactions that follows is the same (i.e., it involves the same species and the
formation of the same intermediates), from here on, for both the extrinsic and intrin-
sic pathways, and is often referred to as the common pathway. The enzyme complex
IXa-VIIIa bound to the membrane of the activated platelet (or negatively charged
phospholipid, to be precise) catalyzes the formation of Xa from X. The membrane
bound IXa-VIIIa complex is termed ‘tenase’. The next important step in this chain is
the formation of enzyme complex Xa-Va on the membrane of the activated platelet.
39
The membrane-bound Xa-Va complex (‘prothrombinase’) catalyzes the production
of thrombin from prothrombin. Thrombin acts on fibrinogen (a plasma protein) to
convert it to yield fibrin monomers that later polymerize and are cross-linked to form
a fibrin matrix. The role of fibrinogen and fibrin in the coagulation reactions has
been highlighted in a recent review [12].
The intrinsic coagulation pathway, is initiated when f-XII upon contact with
a negatively charged surface (in this case, the collagen present in the subendothe-
lial layer) is activated to XIIa by kallikrein. This activation is facilitated by high-
molecular-weight-kininogen. XIIa activates the zymogen, f-XI, to its active enzyme
form, XIa. XIa activates f-IX to IXa in the presence of Ca2+. The reactions that
follow are those of the common pathway, and lead to the formation of thrombin from
prothrombin, and thence of fibrin from fibrinogen. The initiation of the intrinsic
coagulation pathway by f-XII is relevant mainly in the in-vitro setting [37]. The in-
trinsic pathway is of great relevance for the laboratory monitoring of anticoagulation
therapy for, and diagnosis of, coagulation disorders.
The biochemical changes during coagulation involve various positive and negative
feedback loops within the broad framework outlined above. Thrombin and Xa play a
major role in the positive feedback mechanisms by catalyzing the production of almost
all the intermediates required for their production. Antithrombin-III (AT-III), Tissue
factor pathway inhibitor (TFPI), and Active Protein C (APC) play a major role in
inhibiting and regulating the coagulation cascade. The coagulation reactions and
clot formation are known to be affected by mechanical factors like, for instance, the
shear-rate dependence for the kinetics of fibrin formation. There are, thus, several
biochemical changes during, and rheological influences on, the coagulation pathways.
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3. Fibrinolysis
Fibrinolysis is initiated when thrombin and fibrin, formed during coagulation, activate
endothelial cells resulting in enhanced production of tissue plasminogen activator
(tPA) and urokinase-like plasminogen activator (uPA). tPA and uPA catalyze the
transformation of plasminogen into the active enzyme plasmin. tPA is the more
active among these two; its activity increases manifold in association with fibrin.
Plasmin degrades the fibrin polymer into smaller units leading to the dissolution of
the clot.
Like the coagulation pathways that precede it, fibrinolysis has its share of regu-
latory mechanisms. Active Protein C (APC), for example, is an accelarator of fibri-
nolysis. α2-Antiplasmin (L2AP), and PAI-1, are plasma-phase enzymes that inhibit
fibrinolysis by binding to fibrin. Clot dissolution can also occur due to mechanical
factors like high shear stress, and the actual value depends on the composition of
the clot. There are, thus, biochemical changes during, and rheological influences on,
fibrinolysis and clot dissolution.
B. Literature survey of models
Mathematical models for the various stages of, and the several components involved
in, clot formation and dissolution have expanded around the basic view (formulated
in 1964) of the coagulation pathways (leading to thrombin production) as enzyme
cascades [63], [31]. Levine proposed the earliest model (in 1966) for the enzyme
cascade consisting in a set of first order ODEs [60]. Models later simulated the
individual reactions of the coagulation pathway (like, for instance, the generation
and depletion of prothrombinase [73]), and grew in compexity (in the late 1980s) to
include the kinetics of sets of reactions in the enzyme cascade along with feedback
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loops and inhibitors under different reaction conditions (like flow, extent of stimulus,
etc.) [51], [48]. This trend continued so that models of greater complexity consisting
in systems of coupled (linear or non-linear) ODEs [59], [57] and PDEs [126], [6]
for platelet activitation, the coagulation pathways, and fibrinolysis [72], [32], were
developed and have appeared in the literature in recent years (a detailed review of
the literature can be found in [2]). As of the present, no single model has integrated
all aspects of and changes during the formation and dissolution of clots in a single
framework, and the model developed here is a step in this direction.
In the context of this historical trend, several important hypotheses emerged
from the model simulations concerning the phenomenon of hemostasis. Among these,
one of the most important is that of a threshold response of the coagulation pathways
to the activating stimulus (whether, for the extrinsic pathway, the extent of injury,
or, for the intrinsic pathway, the levels of f-XIa at the surface), and the observation
that the threshold response is modulated by several factors (flow, the size of the
injury, the availability of surface binding sites for the various constituents, the levels of
Ca2+, etc.); this hypothesis is observed primarily in the spatially homogeneous setting
(the role of convection and diffusion is incorporated). Other hypotheses, observed
in the context of the spatially inhomogeneous setting, are that the system for the
coagulation pathways cannot return to its preactivation state without a steep drop in
the activating stimulus itself, and the existence of a possible “effector” involved in the
inhibition of clot growth [6]. An important hypothesis generated by the studies using
PDEs to study the growth and elongation of clots in the spatially inhomogeneous
setting is that, under quiescent conditions, the hemostatic mechanism, at least the
coagulation pathways, are best characterized by reaction-diffusion equations in order
to allow for stationary, spatially non-uniform solutions (as first described by Turing
[108]) that mimic the structures that are formed during clot formation and growth.
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Proceeding along this line of thought, a set of coupled convection-diffusion-reaction
equations is postulated, and assumed to be best suited, to capture the influence of
flow on, and the biochemical changes during, clot formation and dissolution in one
single framework.
C. A model consisting in convection-diffusion-reaction equations for the various con-
stituents
The formation, growth and dissolution of clots is modeled by means of a set of
convection-diffusion-reaction equations that govern the transport and generation/depletion
of the various enzymes, proteins and platelets that are involved. This set of equations
is coupled to the balance laws of both blood and clot, and represents a unifying link
with which to pull together the legs of Virchow’s triad. Clot formation is initiated
when an activation threshold in the flux boundary conditions is exceeded (related to
the appearance of TF-VIIa complex on the injured surface, and the generation of XIa
due to contact with the negatively charged collagen in the subendothelium; this is tied
to the extent of the injury). The clot is said to be formed when the concentration of
fibrin ([Ia]) equals or exceeds 600 nM. Clot growth is tied to the progress of the reac-
tions, and is determined by tracking, in time, the extent of these regions. Fibrinolysis
starts as soon as thrombin appears at the surface, and induces a rapid endothelial
cell response. Clot dissolution occurs when fibrin ([Ia]) concentration drops below
600 nM or if the shear stress exceeds a critical value causing the clot to rupture.
The equations governing the movement and generation/depletion of the various
constituents are of the following form:
∂[Yi]
∂t
+ div([Yi]v) = div(DYi(D)∇[Yi]) +GYi; i = 1, ..., 25. (4.1)
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Here, and elsewhere below, [Yi] represents the concentration of the reactant Yi, GYi
represents the production or depletion of Yi due to the enzymatic reactions, v is the
velocity, and DYi represents the diffusion coefficient of Yi which could be a function
of the shear rate (captured by means of the stretching tensor D).
The constituents are assumed to exist at every point in the domain, and that, be-
ing of an extremely small composition, they do not affect the velocity of the bulk flow.
This framework of studying the reaction-diffusion equations coupled to the equations
governing the flow of the continua (blood or clot) allows for a natural extension into a
mixture theory model of interacting continua (involving all the components in blood).
The following constituents are assumed, among the several involved in clot for-
mation and dissolution, to be of primary importance: resting platelets (RP), activated
platelets (AP), fibrinogen & fibrin (I & Ia), prothrombin & thrombin (II & IIa), V &
Va, VIII & VIIIa, IX & IXa, X & Xa, tenase (IXa-VIIIa-AP or ‘Z’), prothrombinase
(Xa-Va-AP or ‘W’), XI & XIa, Antithrombin-III (ATIII), Protein C & Active protein
C (PC & APC), Tissue factor pathway inhibitor (TFPI), α1-Antitrypsin (L1AT),
Tissue Plasminogen Activator (tPA), Plasminogen (PLS) & Plasmin (PLA), and α2-
Antiplasmin (L2AP). The role of the TF-VIIa complex, the generation of XIa at the
surface due to contact activation, subendothelium-platelet interaction (the role of col-
lagen and reactive proteins like vitronection, vWF, etc., in platelet activation, and
the density of platelet binding sites), and endothelial cell tPA generation are included
by means of flux boundary conditions. This list captures the broad aspects of clot
formation but it is by no means comprehensive.
1. Treatment of diffusion coefficients
The diffusion coefficients are tabulated in Table I; all the values are for platelets and
proteins derived from human blood. The values, for platelets in human plasma at
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 
C, are obtained using the Stokes-Einstein formula. The values, for the proteins,
are obtained using a generalized form of the Stokes-Einstein equation (the correlation
in [125]) that allows us to obtain the diffusion coefficients of the proteins in human
plasma at 37
 
C.
Table I.: Diffusion coefficients
Species Mol. Wt. ν¯ (cc/g) Diffusion coefficients (cm2/sec)
RP - - DRP = 1.58× 10
−9
AP - - DAP = 1.58× 10
−9
I 340000 0.723 DI = 3.1× 10
−7
Ia ≈660000 0.730 DIa = 2.47× 10
−7
II 72000 0.719 DII = 5.21× 10
−7
IIa 37000 0.730 DIIa = 6.47× 10
−7
V 330000 0.730 DV = 3.12× 10
−7
Va 179000 0.730 DV a = 3.82× 10
−7
VIII 330000 0.730 DV III = 3.12× 10
−7
VIIIa 166000 0.730 DV IIIa = 3.92× 10
−7
IX 56000 0.730 DIX = 5.63× 10
−7
IXa 41000 0.730 DIXa = 6.25× 10
−7
X 56000 0.730 DX = 5.63× 10
−7
Xa 25000 0.730 DXa = 7.37× 10
−7
XI 160000 0.730 DXI = 3.97× 10
−7
XIa 80000 0.730 DXIa = 5.0× 10
−7
PC 62000 0.730 DPC = 5.44× 10
−7
APC 60000 0.730 DAPC = 5.50× 10
−7
45
Table I.: (continued)
Species Mol. Wt. ν¯ (cc/g) Diffusion coefficients (cm2/sec)
ATIII 58000 0.730 DATIII = 5.57× 10
−7
TFPI 40000 0.730 DTFPI = 6.30× 10
−7
L1AT 51000 0.728 DL1AT = 5.82× 10
−7
tPA 68000 0.730 DtPA = 5.28× 10
−7
PLS 92000 0.715 DPLS = 4.81× 10
−7
PLA 85000 0.715 DPLA = 4.93× 10
−7
L2AP 70000 0.720 DL2AP = 5.25× 10
−7
2. Treatment of reaction kinetics
The reactions chosen to represent the extrinsic and intrinsic coagulation pathways,
the generation of phospholipid binding sites due to platelet activation, the influence
of thrombin on factor XIa generation, the formation of fibrin, and the generation of
plasmin are given in the schematic (Figure 9). The reactions are listed in Table II, the
form of the kinetics governing each constituent is detailed, and the kinetic constants
are summarized in Table III. The reaction kinetic data is from available experiments;
the enzyme kinetic data for all the reactions is for zymogens, enzymes, and platelets
derived from human blood. Complete data for the kinetics governing the activation,
and inactivation, of f-VIII, and f-VIIIa respectively, is not available. Given the large
structural and functional similarities between f-V and f-VIII, the kinetic constants
that govern the reactions involving f-VIII, and f-VIIIa, are assumed to be the same
as those that govern the reactions involving f-V, and f-Va respectively. The kinetic
data for the other zymogens and enzymes is taken from the relevant sources, and
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details regarding the assumptions involved in choosing some of the constants can be
found in a paper that is under preparation [3].
Some interactions, amidst the 25 constituents chosen, have not been included
because of their relative insignificance like, for instance, the effect of Xa on V [69],
and VIII [33], the effect of Xa on prothrombin (insignificant compared to the much
faster reaction catalyzed by prothrombinase; see [55]), the effect of IXa on X [86],
or the role of circulating TF [7]. The role of f-XII, not considered to be of major
importance in the in-vivo setting [37], is included in the boundary conditions as a
means of quantifying the generation of XIa at the surface.
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Fig. 9. Schematic of selected reactions involved in platelet activation, the extrinsic and
intrinsic coagulation pathways and fibrinolysis. Solid lines denote zymogen
activation or enzymatic catalysis. Broken lines denote enzymatic deactivation.
Filled in arrow heads denote zymogen activation. Arrow heads that are not
filled in denote enzymatic catalysis. Open arrow heads with solid lines denote
participation in complex formation.
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Table II.: Scheme of enzymatic reactions.
(Z = IXa-VIIIa-AP , W = Xa-Va-AP)
Activation Inactivation
(1a) k11,K11m XI
IIa
−→ XIa (1b) hA311 XIa + ATIII → XIa-ATIII
(1c) hL111 XIa + L1AT → XIa-L1AT
(2a) k9,K9M IX
XIa
−→ IXa (2b) h9 IXa + ATIII → IXi
(3a) k8,K8M VIII
IIa
−→ VIIIa (3b) h8 VIIIa → VIIIi
(3c) hC8 VIIIa
APC
→ VIIIi
(4a) KdZ VIIIa + IXa
AP
−→ Z
Z
AP
−→ VIIIa + IXa
(5a) k5,K5M V
IIa
−→ Va (5b) h5 Va → Vi
(5c) hC5,HC5M Va
APC
→ Vi
(6a) k10,K10M X
Z
−→ Xa (6b) h10 Xa + ATIII→ Xa-ATIII
(6c) hTFPI Xa + TFPI→ Xa-TFPI
(7a) KdW Va + Xa
AP
−→ W
W
AP
−→ Va + Xa
(8a) k2,K2m II
W
−→ IIa (8b) h2 IIa + ATIII→ IIa-ATIII
(9a) kPC ,KPCM PC
IIa
−→ APC (9b) hPC APC + L1AT→APC-L1AT
(10a) k1,K1m I
IIa
−→ Ia (10b) h1,H1m Ia + PLA → Ii
(11a) kIIa
AP
RP
IIa
−→ AP
(11b) kAP
AP
RP
AP
−→ AP
(12a) ktPA−Ia
PLA
PLS
tPA−Ia
−→ PLA (12b) hPLA PLA + L2AP→PLA-L2AP
KPLAm
The rate of depletion of a zymogen is equal to the rate of its activation into the
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corresponding enzyme. The corresponding enzyme is generated from the zymogen
and is depleted by inactivation due to inhibitors. The generation and depletion of
the 25 constituents is described by the following ordinary differential equations:
d[XIa]
dt
=
k11[IIa][XI]
K11M + [XI]
− hA311 [XIa][ATIII]− h
L1
11 [XIa][L1AT ] = GXIa ,(4.2)
d[XI]
dt
= −
k11[IIa][XI]
K11M + [XI]
= GXI , (4.3)
d[IXa]
dt
=
k9[XIa][IX]
K9M + [IX]
− h9[IXa][ATIII] = GIXa , (4.4)
d[IX]
dt
= −
k9[XIa][IX]
K9M + [IX]
= GIX , (4.5)
[
Z
]
=
[V IIIa][IXa]
KdZ
, (4.6)
d[Xa]
dt
=
k10[Z][X]
K10M + [X]
− h10[Xa][ATIII]− hTFPI [TFPI][Xa] = GXa , (4.7)
d[X]
dt
= −
k10[Z][X]
K10M + [X]
= GX , (4.8)
[
W
]
=
[V a][Xa]
KdW
, (4.9)
d[AP ]
dt
= kAPAP [AP ][RP ] + k
IIa
AP [RP ] = GAP , (4.10)
d[RP ]
dt
= −GAP = GRP , (4.11)
d[IIa]
dt
=
k2[W ][II]
K2M + [II]
− h2[IIa][ATIII] = GIIa , (4.12)
d[II]
dt
= −
k2[W ][II]
K2M + [II]
= GII , (4.13)
d[V IIIa]
dt
=
k8[IIa][V III]
K8M + [V III]
− h8[V IIIa]− hC8[APC] = GV IIIa , (4.14)
d[V III]
dt
= −
k8[IIa][V III]
K8M + [V III]
= GV III , (4.15)
d[V a]
dt
=
k5[IIa][V ]
K5M + [V ]
− h5[V a]−
hC5[APC][V a]
HC5M + [V a]
= GV a , (4.16)
d[V ]
dt
= −
k5[IIa][V ]
K5M + [V ]
= GV , (4.17)
d[APC]
dt
=
kPC [IIa][PC]
KPCM + [PC]
− hPC [APC][L1AT ] = GAPC , (4.18)
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d[PC]
dt
= −
kPC[IIa][PC]
KPCM + [PC]
= GPC , (4.19)
d[ATIII]
dt
= −(h9[IXa] + h10[Xa] + h2[IIa] + h
A3
11 [XIa])[ATIII]= G[ATIII],(4.20)
d[TFPI]
dt
= −hTFPI [TFPI][Xa] = GTFPI , (4.21)
d[L1AT ]
dt
= −hPC [APC][L1AT ]− h
L1
11 [XIa][L1AT ] = GL1AT , (4.22)
d[Ia]
dt
=
k1[IIa][I]
K1M + [I]
−
h1[PLA][Ia]
H1M + [Ia]
= GIa, (4.23)
d[I]
dt
= −
k1[IIa][I]
K1M + [I]
= GI , (4.24)
d[tPA]
dt
= 0 = GtPA , (4.25)
d[PLA]
dt
= ktPA−IaPLA [tPA]− hPLA[PLA][L2AP ] = GPLA , (4.26)
d[PLS]
dt
= −ktPA−IaPLA [tPA] = GPLS , (4.27)
d[L2AP ]
dt
= −hPLA[PLA][L2AP ] = GL2AP . (4.28)
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Table III.: Reaction rates and kinetic constants. The fol-
lowing notation is used: M = Michaelis-Menten kinetics,
F = First order kinetics, S = Second order kinetics.
Reaction Kinetics Parameters Sources
(1a) M k11 = 0.0078 min
−1, K11M = 50 nM [38]
(1b) S hA311 = 3×10
−5 nM−1min−1 [90]
(1c) S hL111 = 1.3×10
−5 nM−1min−1 [90]
(2a) M k9 = 11 min
−1, K9M = 160 nM [95]
(2b) S h9 = 0.0162 nM
−1min−1 [119]
(3a) M k8 = 27.0 min
−1, K8M = 140.5 nM see text
(3b) F h8 = 0.222 min
−1 [74]
(3c) M hC8 = 10.2 min
−1, HC8M = 14.6 nM see text
(4a) S KdZ = 0.56 nM [1]
(5a) M k5 = 27.0 min
−1, K5M = 140.5 nM [69]
(5b) F h5 = 0.17 min
−1 [36]
(5c) M hC5 = 10.2 min
−1, HC5M = 14.6 nM [92]
(6a) M k10 = 2391 min
−1, K10M = 160 nM [83]
(6b) S h10 = 0.347 nM
−1min−1 [119]
(6c) S hTFPI = 0.96 nM
−1min−1 [57]
(7a) S KdW = 0.1 nM [65]
(8a) M k2 = 1344 min
−1, K2m = 1060 nM [55]
(8b) S h2 = 0.714 nM
−1min−1 [119]
(9a) M kPC = 39 min
−1, KPCM = 3190 nM [107]
(9b) S hPC = 6.6×10
−7 nM−1min−1 [45]
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Table III.: (continued)
Reaction Kinetics Parameters Sources
(10a) M k1 = 3540 min
−1, K1m = 3160 nM [107]
(10b) M h1 = 1500 min
−1, H1m = 250000 nM [32]
(11a) F kIIaAP = 22.2 min
−1 [57]
(11b) S kAPAP = 18 nM
−1min−1 [57]
(12a) M ktPA−IaPLA = 12 min
−1, KPLAm = 18nM [64]
(12b) S kL2AP = 0.096 nM
−1min−1 [54]
D. Model corroboration
The model equations are corroborated by comparing the results of simulations with
the experimental data for clot formation and elongation in quiescent plasma on a
monolayer of (tissue-factor generating) fibroblasts, and for the dissolution of (formed)
clots in quiescent plasma.
1. Clot formation and growth in quiescent plasma
The formation and growth of a clot is documented in quiescent platelet poor plasma
(normal human, hemophiliac : A/B) for various surfaces (glass, PTFE, monolayers
of human fibroblasts[76], aortic endothelial cells [75]). The clot growth is followed
by measuring the intensity of scattered light, and the spatio-temporal dynamics of
the phenomenon is thus recorded. The light-scattering intensity is correlated to the
fibrin concentration. The data for the clot growth on a monolayer of (tissue-factor
generating) human fibroblasts [76] is used, the experimental conditions are matched
in the simulations, and the numerical results are matched with the experimentally
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recorded curves for clot growth. In simulating the data, it is assumed that the clot
grows uniformly over the activating surface, so that only one spatial dimension (the
domain is of length ‘L’, and the coordinate ‘x’ varies from 0 to L) and time are
important.
The reaction-diffusion equations (convection is not present in this case) corre-
sponding to the 25 constituents are used, the initial conditions are set to be the
physiologic concentrations of the constituents in human plasma (Table IV), and the
boundary conditions (see below) are picked to account for the simultaneous stimula-
tion of the extrinsic and intrinsic pathways (fibrinolysis is not relevant for this case,
and the boundary conditions are set to account for this fact). The equations are
solved using the ‘pdepe’ routine available in MATLAB.
Table IV.: Initial concentrations for some of the con-
stituents involved in clot formation and dissolution.
Species Initial concentration (nM) Reference
RP 10 [57]
AP 0.5 [93]
I 7000 [66]
Ia 0
II 1400 [66]
IIa 0
V 20 [66]
Va 0
VIII 0.7 [66]
VIIIa 0
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Table IV.: (continued)
Species Initial concentration (nM) Reference
IX 90 [66]
IXa 0
X 170 [66]
Xa 0
XI 30 [15]
XIa 0
ATIII 2410 [10]
TFPI 2.5 [66]
PC 60 [66]
APC 0
L1AT 45000 [28]
tPA 0.08 [14]
PLS 2180 [61]
PLA 0
L2AP 105 [28]
The concentration boundary condition at the end of the domain (x = L) is
∂[Yi]
∂x x=L
= 0 , (4.29)
for all constituents ‘Yi’ (i.e., i = 1,...,25). This condition ensures that this end of the
domain is impermeable to the boundary flux of all the constituents.
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The concentration boundary conditions at the surface (x = 0) are
∂[Yi]
∂x
|x=0 = 0 , (4.30)
for all constituents ‘Yi’ except XIa, XI, IXa, IX, Xa, X, AP, RP, and tPA.
The boundary conditions at the wall for these nine species are as follows:
∂[XIa]
∂x
|x=0 =
φ11[XIIa][XI]
Φ11M + [XI]
L
DXIa
= −
DXI
DXIa
∂[XI]
∂x
|x=0 , (4.31)
∂[IXa]
∂x
|x=0 =
k7,9[IX][TF − V IIa]
K7,9M + [IX]
L
DIXa
= −
DIX
DIXa
∂[IX]
∂x
|x=0 , (4.32)
∂[Xa]
∂x
|x=0 =
k7,10[X][TF − V IIa]
K7,10M + [X]
L
DXa
= −
DX
DXa
∂[X]
∂x
|x=0 , (4.33)
∂[AP ]
∂x
|x=0 = kAP [SUBENDO][RP ]|x=0
L
DAP
= −
DRP
DAP
∂[RP ]
∂x
|x=0 , (4.34)
∂[tPA]
∂x
|x=0 = (k
C
tPA + k
IIa
tPA[IIa]|x=0 + k
Ia
tPA[Ia]|x=0)[ENDO]
L
DtPA
. (4.35)
The details pertaining to the model corroboration (the reduction of the experi-
mental data to fibrin concentration curves, the details concerning the numerical im-
plementation and the kinetic parameters governing the boundary conditions), and the
final results matching the model-generated curves and data, are the subject matter
of a paper that is under preparation [3].
2. Clot dissolution in quiescent plasma
The dissolution of a clot formed from platelet poor plasma, and subject to the action
of tPA introduced into the quiescent plasma surrounding the clot, is recorded [87].
Clot lysis is followed by means of confocal fluorescence microscopy, and the rate of
clot lysis is estimated from these images (Figure 10). The data for the clot extent
in time is used, the experimental conditions are matched in the simulations, and the
numerical results are matched with the experimental data. In simulating the data, it
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is assumed that clot dissolution occurs uniformly, and proceeds radially inward with
time (only one spatial dimension, and time are considered).
The reaction-diffusion equations corresponding to 5 constituents (Ia, tPA, PLS,
PLA, L2AP) are used, the initial conditions are picked appropriately given that there
are two distinct regions (the circular clot region, and the platelet-poor plasma region
surrounding it), and the boundaries of the domain are set to be impermeable. The
equations are solved using the ‘pdepe’ routine in MATLAB.
The details pertaining to the model corroboration (the reduction of the experi-
mental data to the clot extent region, the details of the numerical implementation)
are the subject matter of a paper that is under preparation [3], and the final results
will be presented in that paper.
E. Clinical correlations of model predictions
The predictions of the model are obtained for the case of clot formation and disso-
lution in quiescent (Antithrombin-III deficient and Protein C deficient)plasma on a
thrombogenic surface in-vitro. Only one spatial dimension and time are considered,
and the dynamics of the process are investigated in a 2 mm domain over a time inter-
val of 3600 seconds. The entire set of model equations is studied, with the appropriate
initial conditions (Table IV), and boundary conditions picked to account for a simul-
taneous activation of the extrinsic and intrinsic pathways, and for the fibrinolytic
pathway. The equations are solved using the ‘pdepe’ routine in MATLAB.
The predictions of the time for initiation of clot formation (Figure 11), the max-
imum size reached by the clot before dissolution (Figure 12), and the maximum
concentration of fibrin reached within the clot (tied to the fracture strength of the
clot) during growth (Figure 13) are obtained for varying levels of Antithrombin-III
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and Protein-C deficiency. The initiation times for clotting become very small as AT-
III deficiency reaches 40%, suggesting severe thrombotic complications at such levels.
The results, in general, suggest that AT-III deficiency has far more profound con-
sequences on all these parameters, and thus severe clinical implications, than does
Protein-C deficiency, and this is fully in keeping with clinical data for these hyperco-
agulable states [17], [67]. These results, and their relevance for clinical practice, will
be discussed in complete detail in the paper that is under preparation [3].
57
Fig. 10. Clot lysis: Rearrangements of the fibrin network of a plasma clot during lysis
induced by t-PA present in plasma surrounding the clot. The four consecutive
images were made 20 minutes after the addition of t-PA with 30-s intervals
between the images. Reprinted from [87] with (automatic) permission from
ASBMB.
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Fig. 11. Model predictions of the time for initiation of clot formation, for varying levels
of Antithrombin-III and Protein-C deficiency.
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Fig. 12. Model predictions of the maximum size reached by the clot before dissolution,
for varying levels of Antithrombin-III and Protein-C deficiency.
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Fig. 13. Model predictions of the maximum concentration of fibrin reached within
the clot during growth, for varying levels of Antithrombin-III and Protein-C
deficiency.
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CHAPTER V
CLOTS∗
A clot consists of a fibrin matrix bound to platelet aggregates within which RBCs,
WBCs, and plasma are entrapped. The fibrin fibers typically form a very small part
of the entire structure (less than 1% by volume; see [13]). Clots exhibit viscoelastic
behavior, and this viscoelastic behavior varies dramatically based on the architecture
of the underlying fibrin matrix (see [35]). The time scales over which the clot is con-
sidered a viscoelastic liquid vary significantly based on the fibrin matrix architecture.
A viscoelastic fluid model is developed, and the efficacy of this model in describing the
flow of an intravascular thrombus is tested. The framework within which the model
is developed leads to the clot being characterized by four parameters that govern
the dissipation due to the deformation of the fibrin matrix and the platelets, RBCs,
WBCs and plasma bound to this matrix, the energy stored during the deformation
of the fibrin matrix, and the dissipation due to the motion of the plasma itself. The
model is corroborated with data for oscillatory flow in a small diameter rigid-walled
pipe. The model is then used to make predictions for the apparent viscosity that
would be inferred in steady flow experiments, and the predictions are in keeping with
physical expectations.
A. Composition and rheological behavior of various types of clots
There are three types of clots: fibrin clots, plasma clots and whole blood clots. Fibrin
clots are formed from fibrinogen solutions treated with thrombin. Plasma clots are
formed from plasma after treatment with thrombin and calcium chloride (added to
∗Part of the material presented in this chapter will appear in an article that has
been accepted for publication [4].
61
enhance platelet activation). Whole blood clots are formed in-vitro from (usually
citrated) blood by addition of calcium chloride. In all these clots the fibrin matrix is
formed due to the same basic set of reactions: the polymerization of fibrin monomers
after fibrinogen is acted upon by thrombin, and the cross-linking of the fibrin strands
by the action of XIIIa. Ligated clots are clots where the fibrin fibers are crosslinked
(through the action of XIIIa), whereas unligated clots are those where the fibrin
structure does not have these crosslinks. Clots are also classified based on the pH
and ionic strength during formation: 1. fine fibrin clots are formed at relatively
high pH (around 8.0 and above) and ionic strength (around 0.45M), 2. coarse fibrin
clots are formed at lower pH (around 7.4-7.5) and ionic strength (around 0.15M),
or in conditions that are close to physiological conditions. Coarse fibrin clots are
characterized by extensive lateral aggregation of fibrin strands, the typical diameter
of the fibrin strand bundle being greater than 200
o
A. Fine fibrin clots do not have
such extensive lateral aggregation and consist of single strands of the fibrin polymer,
the typical diameter of the fibrin strand being around 10
o
A. Turbidity measurement
is one of the methods used to detect the diameter of the fibrin strands and the strand
bundles (see [18]).
The creep data for coarse ligated and coarse unligated fibrin clots formed from
human fibrinogen suggest a viscoelastic liquid-like response over time scales of ∼3500
sec and 2500 sec, respectively ([39]). Creep data for fine ligated and fine unligated
fibrin clots formed from human fibrinogen (pH = 8.5, aged for 6 and 7 hours re-
spectively) suggest a viscoelastic liquid-like response over time scales of ∼14000 sec
and 10000 sec, respectively ([70], [71]). Stress relaxation data for a fine unligated
fibrin clot (ph = 8.5, aged for 20 hours) confirm that the time scale over which it
may be considered a viscoelastic liquid is around 10000 sec ([47]). In general, clot
properties are very sensitive to the concentration of fibrinogen and platelets (see [41],
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[42]), hematocrit (volume concentration of RBCs) of blood sample (see [84]), ionic
strength (concentration of NaCl and phosphates) and Ca2+ concentration (see [35]),
the flow conditions (shear rate etc.) during clot formation (see [84]), and the age of
the clot. However, complete data on all these parameters are often not found, or when
given, do not match exactly. The above estimates for the time scales of viscoelastic
liquid-like response are for clots formed under very similar conditions, and aged for
comparable lengths of time.
There are many experimental methods used to record the viscoelastic properties
of clots; notable among these are studies that employ the Weissenberg rheogoniometer
([42]), the Thromboelastograph ([44]), the damped oscillation type rheometer (a list
of references can be found in the review article by Kaibara [49]), and the capillary
viscometer ([104]). Studies characterizing the viscoelastic behavior of clots tend to
report data in terms of linear viscoelastic parameters (G’ and G”, see [78] for an
explanation of these terms). Such data is of little value while corroborating nonlinear
3D models. The stress relaxation (data reporting stress versus time at fixed strain)
and creep data (data reporting strain versus time at fixed stress) for fibrin clots in
[47] and [70] is of more value and can be used to corroborate models. Likewise, the
pressure gradient-volume flow rate data reported for flow of plasma clots in pipes
[103] is also of value while corroborating models.
Over relatively small time scales (10-20 seconds), the rheological behavior of
clots (fibrin, plasma or whole blood) is akin to that of a viscoelastic solid, and an
enhancement of the elastic modulus (G’, see [78] for an explanation of this term) with
strain is reported in such experiments (see [8]). Useful data on the fracture strength
of whole (human) blood clots (and the variation of this fracture strength with the
clot composition) is obtained through such small time scale experiments in [85].
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B. Literature survey of models
There are few constitutive models for clots. While there are many studies that char-
acterize the viscoelastic behavior of clots, few develop rigorous non-linear models for
them. A linear viscoelastic model of the 3 parameter fluid type was developed in
[104] to describe the response of a plasma clot under oscillatory flow conditions. [84]
have proposed a 3-D Maxwell model to describe the behavior of coagulating whole
blood. The structural parameter in their model was adjusted to fit the time-varying
apparent viscosity inferred from steady flow between coaxial cylinders.
C. A viscoelastic liquid model for a coarse ligated plasma clot
A viscoelastic fluid model is developed for describing the behavior of a coarse ligated
plasma clot. The properties of this continuum are assumed to depend on, and regu-
lated by the various biochemical processes that take place and this is reflected in the
basic balance laws for the continuum being coupled to and augmented by a system
of convection-diffusion-reaction equations.
1. Constitutive assumptions
The rate of dissipation ξ associated of the material is defined through
ξ = T ·D− W˙ , (5.1)
where T denotes the Cauchy stress, W the stored enegy, and ξ the rate of dissipation
that is required to be non-negative by virtue of the second law of thermodynamics.
The form chosen for the rate of dissipation in the plasma clot is
ξ = αc
(
Dκp(t) ·Bκp(t)Dκp(t)
)γc
+ ηc1D ·D. (5.2)
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The rate of dissipation is set to be non-negative (α, η1 > 0) so as to satisfy the
second law of thermodynamics.
The Helmholtz potential associated with the elastic response is assumed to be
that of a neo-Hookean material:
W ≡ ρψ =
µc
2
(
IB − 3
)
, (5.3)
where ψ is the specific Helmholtz potential, and µ is the shear modulus.
The particular forms for the rate of dissipation and the stored energy correspond
to that for a mixture of a viscoelastic fluid that has a power-law viscosity and a
Newtonian fluid. Such a choice is appropriate as the plasma clot, that we seek to
model, is a mixture of a viscoelastic fluid (the coarse ligated fibrin matrix with bound
platelets and the few RBCs, which can aggegate and shear-thin, and WBCs that have
not been removed when the plasma is separated from whole blood) and a Newtonian
fluid (the entrapped plasma). The viscoelastic fluid model that arises from these
constitutive assumptions is the generalized version of a spring-dashpot combination
in parallel with a dashpot. The dashpot that is in series with the linear spring
is a special dashpot in that its viscosity has a power law dependence on the rate
of deformation. The dashpot in parallel is the analog of the Newtonian fluid, and
ensures that the resulting model does not exhibit an instantaneous elastic response.
Following the procedure of constrained maximization outlined earlier, the follow-
ing model is obtained:
T = −p1 + S , (5.4)
S = µcBκp(t) + η
c
1D , (5.5)
B
∇
κp(t) = −2
(
µc
αc
)1+2nc(
tr(Bκp(t))− 3λ
)nc[
Bκp(t) − λ1
]
, (5.6)
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λ =
3
tr(B−1κp(t))
, (5.7)
nc =
γc − 1
1− 2γc
; nc > 0. (5.8)
Here p is a Lagrange multiplier which arises from the requirement that the material
be incompressible, and S is the extra stress tensor.
The notation
K
c =
(
µc
αc
)1+2nc
(5.9)
is introduced for the sake of convenience.
The model equations have the same form as those used to characterize the flow of
blood, but the values for the material moduli are different. For instance, the viscosity
of the clot can be as much as thirty times that for blood.
D. Model corroboration
A coarse ligated human plasma clot that has been formed in a small tube, one hour
after coagulation has been initiated, is modeled. The clot fills the lumen of the entire
tube, and is a gel-like material consisting of the fibrin matrix and the entrapped cell
matter and plasma. The clot is subject to oscillatory flow with varying amplitudes of
pressure gradient applied at a frequency of 2 Hz ([103]), which corresponds to a heart
rate of 120 beats per minute. At this frequency, the fibrin matrix (with entrapped
fluid) oscillates as one single structure so that modeling it as a single viscoelastic
fluid is reasonable (There are, typically, two types of flow when a pressure gradient is
applied to a vessel or tube that is filled with a clot: the permeating flow of free fluid
through the pores of the clot, and the structural flow of the fibrin matrix with bound
fluid. The two flows are sometimes in phase with each other, though not necessarily
with the wave form of the applied pressure gradient, depending on the frequency of
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Fig. 14. Flow in a clot-filled vessel; note the two types of flow: permeating, and struc-
tural. Reprinted from [104] with permission from IOS Press.
the applied pressure gradient.). The data is in the form of the components of the
(amplitude of) applied pressure gradient that are in-phase with, and out-of-phase
with, the wave form of the volume flow rate. The component of the pressure gradient
that is in phase with the wave form of the volume flow rate is denoted as P’, and the
component that is out of phase is denoted as P”. The model parameters are fixed so
that the results from numerical simulations match the experimental data.
1. Application to oscillatory flow
The viscoelastic fluid is subject to an oscillatory pressure gradient of the following
form:
−
1
ρc
∂p
∂z
= Acos(wt) . (5.10)
A velocity-pressure solution pair of the form:
v = u(r, t)eˆz , p = p(r, z, t) , (5.11)
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is sought. A time periodic solution is sought for v given that the imposed pressure
gradient is time periodic.
Substituting Equations (5.10),(5.11) into the balance of linear momentum and
assuming that the components of the stress depend only on the radial coordinate
(which is tantamount to specifying the form of the deformation from the instanta-
neous natural configuration to the current configuration), the following equations are
obtained (in non-dimensional form):
∂u∗
∂t∗
= −
∂p∗
∂z∗
+
S∗rz
r∗
+
∂S∗rz
∂r∗
, (5.12)
∂Brz
∂t∗
=
∂u∗
∂r∗
Brr − 2χ(Bκp(t))
R
Ve
Brz , (5.13)
∂Brr
∂t∗
= 2χ(Bκp(t))
R
Ve
(λ− Brr) , (5.14)
∂Bzz
∂t∗
= 2
∂u∗
∂r∗
Brz + 2χ(Bκp(t))
R
Ve
(λ−Bzz) , (5.15)
where
S∗rz =
µc
ρcVe2
Brz +
ηc1
2ρcRVe
∂u∗
∂r∗
, (5.16)
λ =
3Brr(BrrBzz −B
2
rz)
B2rr + 2BrrBzz −B
2
rz
, (5.17)
χ(Bκp(t)) = K
c
(
2Brr +Bzz − 3λ
)nc
, (5.18)
and R, Ve are the pipe radius and characteristic velocity respectively. (Note: Bθθ =
Brr, Brθ = Bθz = 0).
The non-dimensionalisation is as follows: t∗ = tVe/R, w∗ = wR/Ve, u∗ = u/Ve,
r∗ = r/R, z∗ = z/R, S∗rz = Srz/ρ
c
Ve
2, p∗ = p/ρVe2, and A∗ = AR/Ve2 (where ρc =
1025.9 kg/m3 is the density of the plasma clot, R = 0.0927 cm as in the experimental
set-up, and Ve = 0.001 m/s) .
The above PDEs are solved in the domain 0<r<1, for t≥ 0, subject to the
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following boundary condition:
u∗(1, t) = 0 , (5.19)
and the center-line condition:
∂u∗(0, t)
∂r∗
= 0 . (5.20)
The exact solution for oscillatory flow of a Newtonian fluid is used as the initial
condition for the velocity profile, whereas Bκp(t) = 1 is used to obtain an initial guess
for the components Brz, Brr, Bzz.
The (coupled) PDEs are decoupled by treating the PDE for the velocity as an
IBVP, while the PDEs for Brz, Brr, Bzz are treated as IVPs. The coupling is brought
about by means of an iterative process at each time step; the iteration proceeding until
consecutive iteratives are within 10−4 of each other for all variables. It is enough to
fix the boundary conditions for the velocity given the absence of the spatial derivative
for Brz, Brr and Bzz (the components of Bκp(t)). A Backward-Time, Central-Space
(BTCS) scheme is used to discretize the equations (∆r = 0.02, ∆t = 0.0002), and the
resulting system of algebraic equations is solved. The tri-diagonal system of algebraic
equations for the velocity are solved by means of a standard Thomas algorithm, and
the coupled nonlinear algebraic equations for the components of Bκp(t) are solved by
means of the ‘fsolve’ routine in MATLAB.
The results for the parameters agree reasonably well with the experimental data
(Figure 15). A better agreement with experiments could be achieved by modifying
the specific choices for the stored energy and dissipation, but this is not done given
the rudimentary nature of the numerical procedures used here.
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Fig. 15. Comparison of model predictions with experimental data; pressure gradient
components that are in and out of phase with the (wave form of) the resulting
flow rate; Kc = 2.2sec−1, µc = 4.9 N/m2, nc = 0.1 and ηc1 = 0.1Pa · s
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E. Physical relevance of model predictions
The apparent viscosity predicted by the model (the relevant expression has the same
form as that for blood flow) at shear rates of 0.06sec−1 and 650sec−1 is found to be
2.2 Pa ·s and 0.0821 Pa ·s. This is around 30 and 15 times, respectively, the viscosity
of human blood at the corresponding shear rates (0.0736 Pa ·s and 0.005 Pa ·s). This
is in keeping with the expectation that the clot be more viscous than blood. The clot
is also more viscous (1800 to 70 times higher) than the plasma (viscosity of 0.0012
Pa · s) from which it is formed.
In the literature surveyed, no data was found that reported apparent viscosity
data for the coarse ligated plasma clot. Experimental considerations come in the way
of measurements of the clot response to steady pressure gradients across a pipe. The
flow rate is too small to be measured, and when a steady pressure gradient is applied,
very soon after the pressure gradient is applied, the entire gel-like structure gives
way and releases the entrapped plasma that is not bound to the matrix structure. A
discussion of these issues can be found in [4].
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CHAPTER VI
APPLICATION OF MODEL FRAMEWORK TO FLOW PROBLEMS,
SUMMARY, AND DIRECTIONS FOR FUTURE STUDY
The elucidation of Virchow’s triad requires, firstly, a framework that can pull together
the rheological and biochemical changes during the formation and dissolution of clots
in flowing blood. Secondly, this framework must be tested in the various flow regimes
that are encountered in the vasculature so as to gain an insight into the various
factors influencing the phenomenon. The framework consisting of the constitutive
model for blood, the convection-diffusion-reaction equations for clot formation and
dissolution, and the constitutive model for the plasma clot is tested in three simple
flow problems that represent some of the flow regimes that may be encountered in
the human vasculature. The equations that need to be solved are generally complex,
and require sophisticated numerical procedures. In this dissertation, the full system
of equations is solved only for the first flow problem, the equations are formulated but
not solved for the second flow problem, and the models for blood and clot are used
with a very simple activation criterion in presenting results for the third flow problem.
The insights gained from the entire study are then summarized, and directions for
future study are suggested.
A. Application of model framework to simple flow problems
The rheological aspects of the phenomenon of clot formation and dissolution in flowing
blood have not been considered with the depth that they merit in most mathematical
models that have appeared in the literature. Typical simplifying assumptions include
using Newtonian models for describing the flow of blood, neglecting the effect of the
growing thrombus on the flow itself, or neglecting to describe the rheological behavior
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of the clot. A list of studies that have tried to study clot formation and dissolution
in flowing blood can be found in [2]. The approach followed here is an attempt to
overcome the inaccuracies that may be introduced by such assumptions.
1. Quiescent conditions on a plane
The system of (reaction-diffusion) equations that apply to the case of clot formation
and dissolution in quiescent conditions (platelet-poor physiologic plasma) on a plane
are solved, and the results for this case are presented.
The model equations, and the solution procedure, have been detailed in an earlier
chapter. Only one spatial dimension and time are considered, and the dynamics of the
process are investigated over 3600 seconds in a 2 mm domain. The entire set of model
equations is studied, with appropriate initial conditions, and boundary conditions
picked to account for a simultaneous activation of the extrinsic and intrinsic pathways,
and for the fibrinolytic pathway. The equations are solved using the ‘pdepe’ routine
in MATLAB.
The temporal and spatial variations in fibrin (Ia) concentration (tied to the
presence or absence of the clot at any point; [Ia] ≥ 600 nM implies the presence of a
clot) are presented in Figures 16 and 17. The latter provides a value of 5.1 minutes
for the time for the initiation of clot formation.
2. Poiseuille-type flow in a cylindrical annulus
The system of equations that apply for the case of clot formation and dissolution in
(time-varying) poiseuille-type flow conditions (with constant flow rate) in a cylindrical
annulus are presented but they are not solved. The variation in time is due to the
fact that although initially only blood flows, the extent of the flow domain, for both
blood flow and clot flow, changes as the clot grows and dissolves. This problem
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Fig. 16. Temporal evolution of fibrin (Ia) concentration during clot ([Ia] ≥ 600 nM)
formation, elongation, and dissolution in quiescent platelet-poor plasma on a
thrombogenic plane.
has relevance for corroborating the results from the entire framework of models with
experimental data for thrombus formation and dissolution on the subendothelium
of a human artery/vein exposed to citrated whole human blood [106] in an annular
perfusion chamber [11] over a time period of upto 40 minutes. Although the data is
for thrombi that are formed non-uniformly on several parts of the exposed surface, it
is reduced as if the thrombi were formed all over the surface; i.e. given the data for
the percent of the surface covered by thrombi and the average height of the thrombi,
a uniform layer of a thrombus of proportional height is assumed to have been formed.
Further details concerning the corroboration can be found in [2].
The equations prior to the formation of the clot, when only blood flows, are
derived first.
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A flow field of the following form is assumed to exist at each instant of time ‘t’:
v|t = u(r)eˆz , p|t = p(r, z) . (6.1)
It is assumed that the displacement field is such that the components of Bκp(t)|t are
functions of the radial coordinate ‘r’ alone.
At each instant of time a steady pressure gradient of the form
∂p
∂z
|t = −C|t; C|t > 0 , (6.2)
is applied.
Henceforth, the suffix ‘t’ is dropped for the sake of convenience.
Initially, only blood flows in the annular region. The equations governing the
flow, obtained after substituting the model equations for blood into the equation for
the balance of linear momentum, are:
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du
dr
=
(
∂p
∂z
r +
2k1
r
)
1(
µbλ
χb
+ ηb1
) , (6.3)
where
λ =
1[
1 + 1
4(χb)2
(du
dr
)2
] 1
3
, (6.4)
χb = Kb
[
λ
2(χb)2
(
du
dr
)2
]nb
, (6.5)
and k1 is an integration constant that is to be evaluated.
The above equations are to be solved subject to the boundary conditions
u(Ri) = 0 , (6.6)
u(Ro) = 0 , (6.7)
where Ri and Ro are the inner and outer radii of the annular region between the
surface of the mounted vessel segment and the wall of the perfusion chamber. The
average thickness of the human arterial segment that is mounted is 291µm, and the
dimensions of the perfusion chamber (“Original” configuration, see [109]), are Ri =
0.2036 cm, Ro = 0.305 cm.
The solution has to meet the condition:
Q =
∫ Ro
Ri
2pirudr = 160ml/min . (6.8)
This requires an iterative procedure which is implemented.
Equations (6.3)-(6.7) hold as long as whole blood flows through the perfusion
chamber, and clot formation has not been initiated. Clot formation occurs once the
threshold boundary condition has been crossed, and the reactions are sufficiently
advanced in time. Clot formation occurs on the inner wall, and the clot grows into
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the annular gap, reducing the domain where blood flows. The location of the blood-
clot interface at a given instant of time(s|t) is between, or at, the boundaries of the
annulus, i.e., Ri ≤ s|t ≤ Ro.
A flow field of the following form is assumed to exist at each instant of time ‘t’
for blood:
vb|t = u
b(r)eˆz , p
b|t = p
b(r, z) . (6.9)
It is assumed that the displacement field is such that the components of Bκp(t)|t, for
blood, are functions of the radial coordinate ‘r’ alone.
A steady pressure gradient of the form
∂pb
∂z
|t = −C|t; C|t > 0 , (6.10)
is applied in the blood zone, and the same pressure gradient is applied in the clot
zone as well.
The following equations pertain to the flow of blood:
dub
dr
=
(
−C|t r +
2kb1
r
)
1(
µbλb
χb
+ ηb1
) (6.11)
where
λb =
1[
1 + 1
4(χb)2
(du
b
dr
)2
] 1
3
, (6.12)
χb = Kb
[
λb
2(χb)2
(
dub
dr
)2
]nb
, (6.13)
and kb1 is an integration constant that is to be evaluated. These equations are solved
subject to the boundary conditions
ub(s|t) = UINT , (6.14)
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ub(Ro) = 0 . (6.15)
A flow field of the following form is assumed to exist at each instant of time ‘t’
for the clot:
vc|t = u
c(r)eˆz , p
c|t = p
c(r, z) . (6.16)
It is assumed that the displacement field is such that the components of Bκp(t)|t, for
the clot, are functions of the radial coordinate ‘r’ alone.
A steady pressure gradient of the form
∂pc
∂z
|t = −C|t; C|t > 0 , (6.17)
is applied in the clot zone; this pressure gradient is the same as that applied for blood
flow.
The equations pertaining to the flow of the clot (obtained after substituting the
model equations for the clot in the equation for the balance of linear momentum) are:
duc
dr
=
(
−C|t r +
2kc1
r
)
1(
µcλc
χc
+ ηc1
) (6.18)
where
λc =
1[
1 + 1
4(χc)2
(du
c
dr
)2
] 1
3
, (6.19)
χc = Kc
[
λc
2(χc)2
(
duc
dr
)2
]nc
, (6.20)
and kc1 is an integration constant that is to be evaluated. These equations are solved
subject to the boundary conditions
uc(Ri) = 0 , (6.21)
uc(s|t) = UINT . (6.22)
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In addition to solving the two sets of equations for the flow of blood and the flow
of clot, for a given pressure gradient −C|t, the following conditions are to be satisfied
for the balance of mass and linear momentum across the interface:
ub(s|t) = u
c(s|t) = UINT , (6.23)
T brz(s|t) = T
c
rz(s|t) , (6.24)
T brr(s|t) = T
c
rr(s|t) . (6.25)
The density change between blood and clot is neglected in formulating these condi-
tions. This seems reasonable given that the density of human blood (ρb) is 1.05 g/cc,
and the density of a human plasma clot (ρc) is 1.03 g/cc.
In addition, the solution has to meet the condition:
Q =
∫ s|t
Ri
2pirucdr +
∫ Ro
s|t
2pirubdr = 160ml/min . (6.26)
The solution of the blood-clot problem at each instant of time ‘t’, requires two
levels of iteration: One until the conditions in Equations (6.23)-(6.25) are met, and
the other until the condition in Equation (6.26) is met. This procedure is to be
implemented.
3. Oscillatory flow in a rigid-walled pipe
The system of equations that apply for the case of clot formation and dissolution
during oscillatory flow in an infinitely long rigid-walled cylindrical pipe (of radius
‘R’) are too difficult to be solved, and so a very simple activation criterion (in place
of the convection-diffusion-reaction equations and the corresponding criteria) is used
to denote the switch between the model for blood (referred to as Model 1) and the
model for clot (referred to as Model 2); the results yield qualitative insights into the
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results that may be obtained with a larger system of equations.
The model used for blood (Model 1) is the same as that outlined in an earlier
chapter. The parameters for Model 1 are: K1 = 1.2056sec−1, µ1 = 0.0227 Pa, n1 =
0.7525 and η11 = 0.01Pa · s. The density of this liquid is ρ
1 = 1050 kg/m3.
The switch in models between that of blood and that of clot, or activation, is
said to take place upon prolonged exposure to shear stresses above a threshold value
(Tcr). This mimics platelet activation and subsequent aggregation (and, thus, throm-
bus formation) upon exposure to supra-threshold shear stresses (≥ Tcr), and is a very
simplistic view of thrombus formation; however, it is entirely possible that such a
situation is encountered in the circulatory system. To quantify the idea of activation
due to prolonged exposure to supra-threshold shear stresses, a phenomenological acti-
vation number, B(t), is defined (Equation 6.27) and associated of each platelet. The
initial state of the platelets, or the resting platelet, is set to an activation number of
zero (i.e. B(0) = 0). The activation number is defined as follows:
B(t) = B(0) +
1
B0
∫ t
0
ek(
|τrz|
Tcr
−1)H(|τrz| − Tcr)dt (6.27)
H(|τrz| − Tcr) =


1 |τrz| ≥ Tcr
0 |τrz| < Tcr
(6.28)
The activation number can either increase or stay constant reflecting exposure
to time varying shear stresses that are or are not above the threshold value (Tcr),
and platelet activation occurs when a threshold activation number Bthr is reached.
Activated platelets are lysed if the activation number exceeds a critical value, Bdamage,
in the time period tact that it takes for the resting platelet to be activated. In the
special flow field that is considered, it is quite easy to track the activation of platelets
by just verifying the activation number at each point in the flow domain. The idea
of quantifying, and tracking, platelet activation by means of B(t) is based on the
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damage accumulation criterion introduced in [123]. The application to the problem
of clot formation and dissolution is a novelty, however, and this is outlined below.
The criterion for activation and the subsequent use of Model 2 for the clot in
regions where we initially employed Model 1 for blood is:
If B(t− tact) > Bthr and B(t) < Bdamage , (6.29)
Or B(t− tact) = Bthr, B˙(t− tact) > 0 and B(t) < Bdamage , (6.30)
Then Model = Model2 . (6.31)
The criterion for dissolution and the subsequent use of Model 1 where the clot has
dissociated is:
If B(t− tact) > Bthr and B(t) > Bdamage , (6.32)
Then Model = Model1 . (6.33)
The parameters for the activation criterion are B0 = 300s, tact = 0.02s, k = 0.75,
Tcr = 1 Nm
−2, Bthr = 0.0004, Bdamage = 1.
The model used for the clot (Model 2) has the same form as that outlined in an
earlier chapter.
The parameters for Model 2 are: K2 = 1.2056sec−1, µ2 = 0.0227 Pa, n2 = 0.7525
and η21 = 0.04Pa · s; Note that the viscosity term η
2
1 for Model 2 is four times the
viscosity term η11 for Model 1, i.e., the clot while also a viscoelastic liquid is four times
more viscous than blood. The density of this liquid is ρ2 = 1050 kg/m3.
The development of the equations governing this problem is very similar to the
development of the equations governing time-varying poiseuille-type flow in a cylin-
drical annulus, in so-far as the boundary conditions for the domains occupied by blood
and clot and the conditions to be met at the blood-clot interface. The only difference
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Fig. 18. Increase of size of domain of the clot (described by Model 2) (1 - s∗|t) with
time (R = 0.005m)
is that the fluids are subject to an oscillatory pressure gradient, and the equations
that govern the flow of blood and clot are those for oscillatory flow (these have been
developed in earlier chapters). Further details pertaining to the development of the
equations can be found in [2].
The following results are obtained for the moving boundary problem that has
been outlined. Figure 18 tracks the location of s∗|t in time. Figures 19 through 22
document the velocity, shear stress (Note the steep increase in shear stress in the
region occupied by the clot), and normal stresses (Brr and Bzz) at t = 0.05 sec after
the onset of oscillatory flow. Figure 23 documents the variation of centerline velocity
in the course of the 0.05 sec after the onset of oscillatory flow.
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B. Summary
A framework of models for the elucidation of Virchow’s triad has been presented.
The framework consists in a model for the rheological behavior of blood, convection-
diffusion-reaction equations to incorporate the rheological influences on, the biochem-
ical changes during, and the surface modulation of the formation and dissolution of
clots, and a model for the rheological behavior of the clot that is formed.
The model characterizing the rheological behavior of human blood is developed in
a theory with a firm thermodynamic basis, and is the first to incorporate the shear-
thinning attributes, and the deformation-dependent viscoelastic behavior of blood.
The model is corroborated under a set of conditions representative of flow regimes
that are present in the human vasculature, and its predictions for flow reversals under
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pulsatile flow conditions represent an interesting consequence of the experimentally
observed fact that the viscoelastic-behavior of blood is less prominent at high shear
rates (where the Newtonian behavior dominates).
The convection-diffusion-reaction equations represent a unifying link that helps
bring together the legs of Virchow’s triad in a manner that is conducive to numerical
testing under various flow regimes that are of relevance to the development of cardio-
vascular devices. The reaction-diffusion equations are corroborated with experimental
data for clot formation, and clot dissolution in quiescent plasma derived from human
blood. The model predictions for the severity of Antithrombin-III deficiency over
Protein-C deficiency tie in nicely with clinical data, and, with the detailed documen-
tation of the results that is being given in the paper under preparation [3], represent
a positive result for the development of mathematical models (for hemostasis) that
have predictive capability.
The model characterizing the rheological behavior of the clot formed from human
plasma has a rigorous thermodynamic basis, and represents a clear improvement over
earlier models in that it can describe the non-linear viscoelastic response of the clot.
The model is corroborated under conditions representative of flow regimes present in
the vasculature (arterial-type flow), and its predictions of large apparent viscosities
are in keeping with the physical expectation that the clot be more viscous than blood.
The framework of models is tested in three simple flow regimes representative of
conditions in the vasculature. The simulations are performed for the case of quies-
cent conditions in a pool of plasma on a plane, and the results for the growth and
dissolution of clot are in keeping with an intuitive expectation of the process. The
equations for the case of time-varying poiseuille-type flow in a cylindrical annular
region are presented but they are not solved. The case of oscillatory flow in a rigid-
walled cylindrical pipe is studied albeit with a simplified set of models, and the results
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for the growth of the clot lend insights into the phenomenon. The centerline velocity
drops as the clot grows which keeps with physical expectation, and the shear-stresses
encountered in the region of the clot suggest that clot rupture could be abrupt (i.e.
thrombo-embolization could occur) under certain flow conditions.
C. Directions for future study
There are several limitations that need to be addressed with each component of the
framework and also with the testing in flow problems, and extensions can be made
in several directions.
The constitutive model for blood treats blood as a homogenized continuum, and
has the inherent limitation that one cannot infer the distribution of the individual
components during the flow, nor can the interaction between these components be
inferred. A first step in this direction would be the development of a mixture theory
model for blood that has separate constitutive equations for RBCs, and plasma, and
constitutive specifications for the interaction between these components. Another
issue with the model for blood is that the choice for the rate of dissipation and
the stored energy function necessitates the introduction of the Heaviside function to
address the issue of the zero-shear viscosity. This is a cumbersome detail, and a better
choice for the rate of dissipation and stored energy function must be made to address
this issue. One step in this direction would be to explore making a choice for the rate of
dissipation that corresponds to a generalized-Maxwell and a generalized-Newtonian
(power-law) liquid. Such a choice would make the model easier for mathematical
analysis. The model for blood is also limited in that the effect of hematocrit on the
property variations is not incorporated, and steps in this direction should be taken.
The convection-diffusion-reaction equations for the formation and dissolution of
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clots in flowing blood represent an initial attempt to develop a model incorporating
the relevant mechanical and biochemical changes during the complete process. This
model is, by no means, comprehensive, and several constituents (like f-VII, f-XIII,
Protein S, etc.) and details concerning their interactions (like the incorporation of
separate binding sites for enzyme complexes on the membrane of activated platelets)
need to be added to lend completeness to the model. A discussion on some of the
steps that can be implemented to extend these equations is found in [2].
The constitutive model for the clot suffers from some of the same limitations
as the model for blood in that it treats a porous fibrin matrix bound to platelets
and permeated by entrapped plasma as a homogenized continuum. The interactions
between the constituents, though highly relevant for oscillatory and pulsatile flow,
cannot be captured by means of this approach. A first step to address this limita-
tion would be the development of a mixture theory model for the clot with separate
constitutive equations for the fibrin matrix and the RBC-platelet-plasma aggregate
and constitutive specifications for the interactions between them. The variation of
clot properties with factors like the age of the clot, the extent of ligation, and the
pH during formation are also steps that should be taken. In addition, the clot prop-
erties could be tied to the progress of the fibrin polymerization reactions (something
which is not done right now). As such, of course, the results obtained during the
model corroboration seem to suggest that a different choice for the rate of dissipation
and the stored energy function would yield a better fit with the experimental data,
apart from redressing the rather cumbersome detail of the Heaviside function that is
introduced right now.
The testing of the framework in the simple flow problems opens up several nu-
merical issues that need to be addressed if reliable results and, thus, a better under-
standing of the phenomenon are to be obtained. The entire set of equations from
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using the framework of models need to be solved for both the time-varying poiseuille-
type flow, and also for the case of the oscillatory flow in a rigid-walled pipe. The
results from these studies would, hopefully, shed insight into, among other facets of
the phenomenon, the manner of clot dissolution (whether gradual or abrupt, and the
probability of thrombo-embolisms being formed). An ambitious step for the future
would be to apply the framework to the complex flow geometry of a heart pump; such
a study would be a key facet in the development of reliable cardiovascular devices
that can be used to reduce the suffering of patients.
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